Tender Ref. No BMSICL/DRUGS/01/2013)

BID DOCUMENT FOR SUPPLY OF DRUGS & MEDICINES FOR VARIOUS
MEDICAL INSTITUTIONS OF GOVT. OF BIHAR FOR THE YEAR 2013-14
(Tender Ref. No BMSICL/DRUGS/01/2013)
BIHAR MEDICAL SERVICES AND INFRASTRUCTURE CORPORATION LTD. (BMSICL)
DEPARTMENT OF HEALTH, GOVT. OF BIHAR
5th FLOOR, BISCOMAUN BHAWAN,GANDHI MAIDAN,PATNA-800001
WWW.BMSICL.GOV.IN
CONTACT NO.0612-2219634,2219635
1
BIHAR MEDICAL SERVICES AND INFRASTRUCTURE CORPORATION LTD.
5th FLOOR, BISCOMAUN BHAWAN, GANDHI MAIDAN, PATNA-800001
CONTACT NO.0612-2219634, 2219635
MANAGING DIRECTOR,BMSICL INVITES THETENDER FOR THE SUPPLY OF DRUGS AND MEDICINES TO
WAREHOUSE OF BMSICL FOR THE YEAR 2013-14
TENDER REFERENCE : BMSICL/DRUG/01/2013, dt…………
DATE OF COMMENCEMENT OF SALE OF TENDER: 18.02.2013
TENDER DOCUMENT PRE-BID MEETING WILL BE AT: at 11.00 A.M. on 28.02.2013 at 5TH FLOOR
BISCOMAUN BHAWAN,PATNA-800001
LAST DATE FOR SALE OF TENDER DOCUMENT : 14.03.2013 UPTO 5.00 P.M.
LAST DATE AND TIME FOR RECEIPT OF TENDER : ` 15.03.2013 Up to 11.30 A.M.
TIME AND DATE OF OPENING OF TENDER : 15.03.2013 at 12.30 P.M.
PLACE OF SUBMISSION AND OPENING OF TENDER : 5TH FLOOR,BISCOMAUN BHAWAN, PATNA-1
Cost of the Tender Document Rs.5000/- (Rs.250 .00 Extra for postal charges)
2
TABLE OF CONTENTS
Sr. No. Particulars Clause No.

1 Validity of Bids 1
2 Eligibility Criteria 2
3 General Conditions of Contract 3
4 Technical Bid 4
5 Price Bid 5
6 Opening of Tenders 6
7 Earnest Money Deposit 7
8 Earnest Money Deposit exemption 8
9 Other Conditions 9
10 Acceptance of Tender 10
11 Security Deposit 11
12 Agreement 12
13 Supply Conditions 13
14 Logogram 14
15 Packing 15
16 Quality Testing 16
17 Payment Provisions 17
18 Deductions in Payment 18
19 Quality Control Deductions and Other Penalties 19
20 Blacklisting Procedures 20
21 Registration 21
22 Saving Clause 22
23 Jurisdiction 23
24 Table of Annexures -
3
TENDER FOR THE SUPPLY OF DRUGS AND MEDICINES FOR VARIOUS
MEDICAL INSTITUTIONS OF GOVT. OF BIHAR FOR THE YEAR 2013-14
MANAGING DIRECTOR BIHAR MEDICAL SERVICES AND INFRASTRUCTURE CORPORATION LTD. FOR & ON
BEHALF OF DEPARTMENT OF HEALTH, GOVERNMENT OF BIHAR (GoB), (hereinafter referred as Tender Inviting
Authority unless the context otherwise requires) invites TENDER FOR THE SUPPLY OF DRUGS AND MEDICINES
TO VARIOUS MEDICAL INSTITUTIONS OF GOVT. OF BIHAR FOR THE YEAR 2013-14.
GENERAL INSTRUCTIONS TO BIDDERS;
1. VALIDITY OF BIDS :
The bids shall be valid for a period of 120 days from the date of opening of Cover A (TECHNICAL BID) and prior
to the expiration of the bid validity; the Tender Inviting Authority may request the tenderers to extend the bid
validity for another period of 30 days or so depending on the requirment. The tenderer may refuse extension of
bid validity without forfeiting the Earnest Money deposit,but those who are willing to extend the validity of
their bid shall also be required to provide an extension of earnest money as specified in the tender documents.
2. ELIGIBILITY CRITERIA
(a) Tenderer shall be a manufacturer having their own valid manufacturing license or direct importer holding
valid import license. Distributors / Suppliers / Agents / Loan licensee are not eligible to participate in the
Tenders.
(b) Average Annual turnover in the last three years i.e. 2009-10, 2010-11 and 2011-12 of the bidder shall not be
less than Rs. 10 Crores for Medicines and Rs.5.00 Crores for Surgical items & consumables.
(c) (i) Tenderer must have at least 3 years Market Standing as a manufacturer / importer for each drug quoted
in the tender. ii) Tenderer should have permission to manufacture/import the item /drug quoted as per
specification in the tender from the competent authority.
(d) Tender should not be submitted for the product/ products for which the concern / company has been
blacklisted /debarred either by Govt. of Bihar / Central Government/any state Govt. or by any agency of the
Central Government or State Government and whose blacklisting/debarred period is still valid .
3. GENERAL CONDITIONS.
(i) A complete set of tender documents may be purchased by any interested eligible person of the tenderer on
an application in writing and upon payment of a non refundable fee of Rs.5000/-plus postal fee of Rs.250/-if
applicable, in the form of Demand draft drawn in favor of “Managing Director , Bihar medical Services and
Infrastructure Corporation Ltd.” payable at Patna.
(ii) Tender document may be purchased from the office of BMSICL situated at 5th Floor, Biscomaun Bhawan,
PATNA-1 between 10.00 A.M. to 5.00 P.M. from 18.02.2013 to 14.03.2013 on all working days (Monday to
Friday) either in person or by post. Tender Inviting Authority will not be responsible in any way for postal delay.
(iii) Bidders may also download the bid document directly from the BMSICL website at www.BMSICL.gov.in. In
such case, the bidders are required to submit the tender cost(non refundable) by way of separate Demand
Draft , in the form of Demand draft drawn in favor of “Managing Director , Bihar medical Services and
4
Infrastructure Corporation Ltd.” payable at Patna and the same must be enclosed with Cover A-Technical Bid.
The Bidder should specifically superscribe, ”DOWNLOADED FROM WEBSITE” on the top left corner of the outer
envelope containing Cover A and Cover B. In no case, the tender cost should be mixed with EMD amount. The
bidders not following the above procedure will summarily rejected.
(iv) All tenders must be accompanied with Earnest Money Deposit as specified in clause 4.1(a) of the Tender
document.
(v) A pre-bid meeting will be held at 11.00 AM on 28.02.2013 at 5th Floor, Biscomaun Bhawan,Patna-800001 to
clarify any queries from bidders. Those who wish to attend the same may do so at their own cost. If any
amendment is required in the bid document, following the pre bid conference, it would be posted on the
website. Tenders will be opened in the presence of bidders / authorized representatives who choose to attend
the same at their own cost on the specified date and time, at 5th Floor, Biscomaun Bhawan,Patna-01.
(vi) At any time prior to the date of submission of Tender, Tender Inviting Authority may, for any reason,
whether on his own initiative or in response to a clarification requested by a prospective bidder, modify the
condition of Tender documents by an amendment. In order to provide reasonable time to take the amendment
into account in preparing their bid, Tender Inviting Authority may at his own discretion, extend the date and
time for submission of tenders.
(vii) Interested eligible bidders may obtain further information in this regard, if any, from the office of the
Tender Inviting Authority.
4. TECHNICAL BID -COVER “A”
4.1 The tenderer should furnish the following in a separate cover hereafter called "Cover A".
(a) Earnest Money Deposit shall be as per clause 7 of EMD in the form of Demand Draft drawn in favor of
Managing Director, Bihar Medical Services and Infrastructure Corporation Ltd from any scheduled bank which
will be payable at Patna.
(b) Documentary evidence for the constitution of the company /Firm such as Memorandum and Articles of
Association, Partnership Deed etc. with details of the Name, Address, Telephone Number, Fax Number, e-mail
address of the firm and of the Managing Director / Partners / Proprietor.
(c) The tenderer should furnish notarized and attested photocopy of the valid License for the product duly
approved by the Licensing authority for each and every product quoted as per specification in the tender. The
license must be renewed and valid . The items quoted shall be clearly highlighted in the copy of approved
product list of the license.
(d) Notarised and attested photocopy of the valid import license in Form 10 accompanied with Form 9 and
Form 41 (as per Rule 122A of Drugs and Cosmetics Act) of the quoted imported products, showing clearly that
the quoted products are being imported and marketed in India since last three years. if the product is
imported. The license must have been renewed up to date. A copy of a valid license for the sale of Drugs
imported by the firms issued by the licensing authority shall also be attached.
(e) The instruments such as power of attorney, resolution of board etc., authorizing an officer of the tenderer
should be enclosed with the tender duly signed by the Authorized signatory of the Company / Firm and such
authorized officer of the tenderer should sign and deal with the tender documents.
(f) Market Standing Certificate of minimum last three years issued by the Licensing Authority as a
Manufacturer for each quoted drug .
5
(g) Non-conviction Certificate issued by the Drugs Controller of the State certifying that the bidders have not
been convicted during last three years.
(h) Current Good manufacturing practices Certificate (cGMP) as per revised Schedule-‘M’ (for manufacturers
only) issued by the Licensing Authority. The Importer should produce the WHO GMP with Certificates of
pharmaceutical products (CoPP) of the manufacturing firm. The tenderer shall also furnish a notarized affidavit
in the format given in Annexure-III declaring that the tenderer complies the requirements of cGMP (as per
revised Schedule-‘M’).
(i) Copy of Income Tax return for Assessment Year 2010-11,2011-12,2012-13 must be enclosed.
(j) An affidavit before the Magistrate/ Notary stating that “the company has not been blacklisted either by
Govt. of Bihar / Central Government/any agency of Central Government or State Government. If yes then
indicate blacklisting period.
(k) Copies of the Audited Balance Sheet and Profit and Loss Account for the last three financial years i.e. 2009-
10, 2010-11, 2011-12.
(l) Copy of valid sale tax/vat registration.
(m) The tender document should be signed by the tenderer in all pages with office seal and should be serially
numbered..
(n) All Annexure duly filled, signed by the bidder except the Annexure-XIII & Annexure-XIV and also all the
submitted documents must be attested.
(o)Technical Evaluation Chart-Annexure XVII must be filled along with page no. details otherwise bid will not be
considered for Technical Evaluation. A soft copy of the filled Annexure XVII should be provided in non writable
CD.
(p) No further opportunity will be provided to submit the additional documents after opening of tender.
4.2. The above documents should be numbered and sealed in a separate cover superscribed as "TECHNICAL BID
-COVER “A” -TENDER FOR THE SUPPLY OF DRUGS AND MEDICINES TO VARIOUS MEDICAL INSTITUTIONS OF
GOVT. OF BIHAR FOR THE YEAR 2013-14 DUE ON 15.03.2013 AT 11.30 A.M. TO BE ADDRESSED TO “THE
MANAGING DIRECTOR, BIHAR MEDICAL SERVICES AND INFRASTRUCTURE CORPORATION LTD (ON BEHALF OF
DEPT. OF HEALTH GOVT. OF BIHAR), 5th FLOOR BISCOMAUN BHAWAN,PATNA-800001
5. PRICE BID - COVER ”B”
1. Cover “B” will contain Price Bid of the Tenderer.
(i) Bid should be typewritten and every correction and interlineations in the bid should be attested with full
signature by the tenderer, failing which the bid will be treated as invalid. Corrections done with correction fluid
should also be duly attested.
(ii) Each page of the price bid should be duly signed by the tenderer affixing the office seal.
(iii) (a) The tenderer shall quote in the rate in the Annexure-XIII & XIV for item(s) quoted and also in the Non
Writable Compact Disc (CD) and such filled up in Annexure-XIII and Annexure-XIV along with the Compact Disc
(CD) (Soft Copy) should be submitted in a sealed cover superscribed as FINANCIAL BID – COVER –‘B’
(iv) The rate quoted per unit or landed price in Annexure-XIV shall be inclusive of all central duties such as
customs duty and central excise duty etc. except the sales tax /vat .
(v) The details of rates and manufacturing capacity given in Annexure-XIII and XIV should also be entered
clearly in the Non Writable Compact Disc (CD) as per the instructions given along with the tender. In the event
of any dispute, entries made in the Non Writable CD shall be treated as final and it will prevail upon the
submitted price bid in hard copy.
6
5. (2). The tenderers shall submit duly signed Annexure-XIII and Annexure-XIV and soft copy of Annexure-XIII
and Annexure-XIV (Non Writable Compact Disc (CD)) in a sealed cover Superscribed as “PRICE BID-COVER “B” -
TENDER FOR THE SUPPLY OF DRUGS AND MEDICINES TO VARIOUS MEDICAL INSTITUTIONS OF GOVT. OF BIHAR
FOR THE YEAR 2011-12”. The "Cover B" should also be addressed to MANAGING DIRECTOR BIHAR MEDICAL
SERVICES AND INFRASTRUCTURE CORPORATION LTD. DEPARTMENT OF HEALTH, GOVERNMENT OF BIHAR
,5TH FLOOR,BISCOMAUN BHAWAN,PATNA-800001.
5. (3). Two separately sealed covers {Technical bid (Cover “A”) {Refer Clause No.4.2} and Price Bid (Cover “B”)} {
Refer clause 5.(2) } shall be placed in a cover which shall be sealed and Superscribed as “TENDER FOR THE
SUPPLY OF DRUGS AND MEDICINES TO VARIOUS MEDICAL INSTITUTIONS OF GOVT. OF BIHAR FOR THE YEAR
2013-14 DUE ON 15.03.2013 AT 11.30 A.M. and addressed to MANAGING DIRECTOR, BIHAR MEDICAL
SERVICES AND INFRASTRUCTURE CORPORATION LTD. ,DEPARTMENT OF HEALTH, GOVERNMENT OF BIHAR ,
5TH FLOOR,BISCOMAUN BHAWAN,PATNA-800001 which shall be submitted within the date and time as
specified in Clause 1(a).
5. (4). If the last date for submission of Tender is declared a holiday, the tenders may be submitted on the next
working day up to 11.30A.M.
6. OPENING OF COVER “A” AND COVER “B” OF TENDER
(a) All the tenderers are entitled to be present at the date and time for opening of Technical Bid -Cover “A” of
the tender submitted by them.
(b) The tender will be scrutinized by tender evaluation committee formed by BMSICL and inspection of
manufacturing unit for compliance of GMP would be carried out by the technical committee constituted for this
purpose. Tenderers, who were found eligible on satisfying the criteria for technical evaluation and inspection,
will only be invited to be present at the date and time for opening of Price Bid -Cover “B” of the tender.
7. EARNEST MONEY DEPOSIT The Earnest Money Deposit referred to at Clause 4.1(a) shall be Rs.2,00,000/-
(Two Lakh only) for Medicines and Rs.50,000/-(Fifty Thousand only) for surgical items and consumables. In
case tenderer is quoting for both medicines and surgical items & consumables have to deposit Rs.2,50,000/-
(Two Lakh Fifty Thousand only).The Earnest Money Deposit shall be paid in the form of Demand Draft, favoring
Managing Director, Bihar Medical Services and Infrastructure Corporation Ltd issued from any Scheduled Bank
and payable at Patna.This should be enclosed with the tender in Cover “A”. Earnest Money Deposit in the form
of Cheque / Cash / Postal order/FDR will not be accepted. No interest shall be paid on the EMD.
8. EARNEST MONEY DEPOSIT EXEMPTION
(1) No exemption from payment of EMD is permitted except the small scale units in Bihar. They will have to
deposit only 20 percent of the general security amount.
(2). (i) The tenders submitted without sufficient EMD will be summarily rejected.
(ii) The Earnest Money Deposit of the Tender will be forfeited without further notice:
a. If it is found that the manufacturing unit of the tenderer does not comply with cGMP but furnished an
affidavit as in Annexure-III.
b. Any bidder withdraws his offer within the bid validity period before finalization of the tender.
c. On refusal to enter into a contract after the award of contract.
d. In any party accepts the purchase order but does not supply within 30 days from the date of
acceptance of the purchase order.
7
9. OTHER CONDITIONS
i). The orders will be placed by the Managing Director, Bihar Medical Services and Infrastructure Corporation
Ltd or other competent official authorized by BMSICL (hereinafter referred to as Ordering Authority) in their
respective jurisdictions;
ii). The details of the required drugs, medicines, etc., are shown in Annexure-VI. The quantity mentioned is only
the tentative requirement and may increase or decrease as per the decision of Ordering Authority. The rates
quoted should not vary with the quantum of the order or the destination.
iii) Tender has been called for in the generic names of drugs. The tenderers should quote the rates for the
generic products only. The composition and strength of each product should be as per details given in
Annexure-VI. Any variation, if found, will result in the rejection of the tender.
iv) Rates (inclusive of Excise Duty, Customs duty, transportation, insurance, and any incidental charges, but
exclusive of Sales Tax/VAT) should be quoted for each of the required drugs, medicines etc., and separately on
door delivery basis. The delivery should be made as stipulated in the purchase order placed with successful
tenderers.
v) The price quoted by the tenderers shall not, in any case exceed the controlled price/ceiling price, if any,
fixed by the Central/State Government and the Maximum Retail Price (MRP). Tender Inviting Authority at its
discretion, will exercise, the right to revise the price at any stage so as to conform to the controlled /ceiling
price or MRP, as the case may be. This discretion will be exercised without prejudice to any other action that
may be taken against the tenderer.
vi) The rates quoted and accepted will be binding on the tenderer during validity period of the bid and any
increase in the price (except increase due to Excise Duty) will not be entertained during the validity period of
Tender.
vii) No tenderer shall be allowed at any time on any ground, whatsoever it may be, to claim revision or
modification in the rates quoted by him. Representation to make correction in the tender documents on the
ground of Clerical error, typographical error, etc., committed by the tenderers in the Bids shall not be
entertained after submission of the tenders. Conditions such as “SUBJECT TO AVAILABILITY” “SUPPLIES WILL BE
MADE AS AND WHEN SUPPLIES ARE RECEIVED” etc., will not be entertained under any circumstances and the
tenders of those who have given such conditions shall be treated as incomplete and accordingly the Tender will
be rejected.
viii) BMSICL shall make the agreement with L1 declared bidders and Purchase order will be issued to L1
declared bidder only and if there is more than one L1,the supply quantity will be equally distributed. In case L1
declared bidder either fails to supply the required items in full quantity or make the delayed supply, the same
will be purchased from the L2 bidders at L2 rate and differential amount of L1 and L2 will be recovered from
the L1 bidders.
ix) Blood products should be supplied only after getting HIV and Hepatitis-B screening certificate. A copy of
these Certificates should be sent with every consignment and every invoice.
x) Supplies should be made directly by the bidder and not through any other agency.
xi) The tenderer shall allow inspection of the factory at any time by a team of Experts/Officials of the Tender
Inviting Authority and or of the Govt. of Bihar. The tenderer shall extend all facilities to the team to enable to
8
inspect the manufacturing process, quality control measures adopted etc., in the manufacture of the quoted
items. If a Company/Firm does not allow or put any obstruction in carrying out such inspection, their tender
shall be summarily rejected.
10. ACCEPTANCE OF TENDER
i) The rate evaluation committee formed by Managing Director, Bihar Medical Services and Infrastructure
Corporation Ltd will evaluate the tender with reference to various criteria and the successful bidder shall be
selected by the rate evaluation committee taking quoted rate (Landed Price without Sales Tax/VAT) of the
bidder into consideration.
ii) Tender Inviting Authority reserves the right to accept or reject the tender for the supply of all or any one or
more items of the drugs tendered for, in a tender without assigning any reason.
iii) Tender Inviting Authority, or his authorized representative(s) or the authorized representative(s) of Govt. of
Bihar has the right to inspect the factories of tenderers, before, accepting the rate quoted by them or before
releasing any purchase order(s) or at any point of time during the continuance of tender and also has the right
to reject the tender or terminate / cancel the purchase orders issued and or not to reorder, based on adverse
reports brought out during such inspections.
iv) The acceptance of the tenders will be communicated to the successful tenderers in writing by the tender
inviting authority.
v) The rates of the successful tenderers would be valid for one year from the date of issue of first purchase
order which may be extended for maximum of further 3 months by mutual consent of both the purchaser and
supplier.
11. SECURITY DEPOSIT : The Successful Tenderer shall be required to pay Security Deposit of 10% of the
estimated consumption value as detailed below:
a) They have to submit the performance guarantee of 5% of the estimated consumption value before entering
into agreement in the form of Fixed Deposit Receipt (pledged to Managing Director, Bihar Medical Services and
Infrastructure Corporation Ltd) or Demand Draft or Bank Guarantee drawn in favour of “the Managing Director,
Bihar Medical Services and Infrastructure Corporation Ltd”, payable at Patna , viz. Tender inviting authority
before releasing the purchase order by the ordering authority.
b) Balance 5% will be deducted from the running bill of the Tenderer.
12. AGREEMENT
(a) The successful tenderer shall execute an agreement on a non-judicial stamp paper of value of Rs.100/-
(stamp duty to be paid by the tenderer) within 10 days from the date of the intimation with the Tender Inviting
Authority, viz., the Managing Director, Bihar Medical Services and Infrastructure Corporation Ltd.. The
Specimen form of agreement is available in Annexure-VIII.
(b) The tenderer shall not, at any time, assign, sub-let or make over the contract or the benefit thereof or any
part thereof to any person or persons what so ever
(c) All notices or communications relating to arising out of this agreement or any of the terms thereof shall be
considered duly served on or given to the tenderer if delivered to him or left at the premises, places of business
or abode..
9
13. SUPPLY CONDITIONS
i) Purchase orders along with the delivery destinations (normally at Fathuha, Purnia, and Muzaffarpur) will be
placed on the successful tenderer as per requirement and discretion of the Ordering Authority .
ii) All supplies will be scheduled for the period from the date of acceptance till the completion of the tender in
installments, as may be stipulated in the Purchase Order. The supplied medicines and Drugs (covered in
Schedule-P of Drugs and Cosmetics Act) should have a maximum potency throughout the shelf life period as
prescribed in the Drugs and Cosmetics Act 1940 and rules there under. The medicines and Drugs should be
supplied within 60 days from date of manufacture. All drugs supplied should have at least a minimum of 3/4th
of the shelf life of the drug supplied at the time of supply.
iii) The tenderer must submit a Test Analysis report from for every batch of drug supplied along with invoice. In
case of failure on the part of the supplier to furnish such report, the batch of drugs will be returned back to the
suppliers and he is bound to replenish the same with a copy of test . The Drugs and medicines supplied by the
successful tenderer must comply with the specifications, stipulations and conditions specified in the Annexure.
4. Tenderer shall supply the product, at the designated places within 30 days from the date of receipt of
purchase order.
5. BMSICL shall make the agreement with L1 declared bidders and Purchase order will be issued to L1 declared
bidder only. In case L1 declared bidder either fails to supply the required items in full quantity or make the
delayed supply, the same will be purchased from the L2 bidders at L2 rate and differential amount of L1 and L2
will be recovered from the L1 bidders.
6. It shall be the responsibility of the supplier for any shortages/damage at the time of receipt in the designated
places. Ordering Authority is not responsible for the stock of drug received, for which no order is placed.
7. The supplier shall take back Drugs, which are not utilized by the ordering authority within the shelf life period
based on mutual agreement.
8. If at any time the tenderer has, in the opinion of the ordering authority, delayed in making any supply by
reason of any riots, mutinies, wars, fire, storm, tempest or other exceptional cause on a specific request made
by the tenderer within 7 days from the date of such incident, the time for making supply may be extended by
the ordering authority at its discretion for such period as may be considered reasonable. The exceptional
causes do not include the scarcity of raw material, power cut, labour disputes etc.
9. In the event of items of drugs supplied found to be not as per specifications in respect of their packing, the
Ordering Authority is at liberty to make alternative purchase of the items of drugs and medicines for which the
Purchase orders have been placed from any other sources or in the open market or from any other tenderer
who might have quoted higher rates at the risk and the cost of the supplier and in such cases the ordering
authority has every right to recover the cost and impose penalty as mentioned in Clause 18 and 19 of contract.
14. LOGOGRAMS
Logogram means, wherever the context occurs, the design as specified in Annexure-II.
i) Tenders for the supply for Drugs and medicines etc., shall be considered only if the tenderer gives
undertaking in his tender that the supply will be prepared and packed with the logogram either printed or
embossed on tablets and capsules, bottles etc., as per the design enclosed as per Annexure-II.
10
ii) All tablets and capsules have to be supplied in standard packing with printed logogram and shall also
conform to Schedule P1 of the Drugs & Cosmetics Act & Rules wherever it applies. Affixing of stickers and
rubber stamps shall not be accepted.
iii) Vials, Ampoules and Bottles containing the items tendered for should also carry the logogram.
iv) Failure to supply Drugs etc., with the logogram will be treated as breach of the terms of agreement and
liquidated damages will be deducted from bills to bidders.
15. PACKING
i) The Drugs and medicines shall be supplied in the package specified in Annexure-VII and the package shall
carry the logograms specified in Annexure-II.
ii) The packing in each carton shall be strictly as per the specification mentioned in Annexure-VII. Failure to
comply with this shall lead to non-acceptance of the goods besides imposition of penalties.
iii) The labels in the case of injectables should clearly indicate whether the preparations are meant for IV, IM,
SC, etc.
iv) The strip/blister pack/bottle shall have the name of the drug, in addition to the logo.
v) It should be ensured that only first hand fresh packaging material of uniform size including bottle and vial is
used for packing.
vi) All primary packing containers should be strictly conforming to the specification included in the relevant
pharmacopoeia.
Vii) Packing should be able to prevent damage or deterioration during transit.
16. QUALITY TESTING
i) Samples of supplies of each batch will be chosen at the point of supply or distribution / storage points for
testing. (The samples would be sent for the purpose of test and analysis by the ordering authority ). 2% of the
purchase value shall be deducted towards handling and testing charges by ordering authority for the above
purpose.
ii) The Drugs shall have the active ingredients at the maximum permissible level throughout the shelf life period
of the drug. The samples will be drawn periodically throughout the shelf life period. The supplies will be
deemed to be completed only upon receipt of the quality certificates from the laboratories. Samples which do
not meet quality requirements shall render the relevant batches liable to be rejected. If the sample is declared
to be Not of Standard Quality or spurious or adulterated or mis-branded, such batch/batches will be deemed to
be as rejected supplies.
iii) In the event of the samples of Drugs and medicines supplied failing quality tests or found to be not as per
specifications the ordering authority is at liberty to make alternative purchase of the items of drugs and
medicines for which the Purchase orders have been placed from any other sources or in the open market or
from any other tenderer who might have quoted higher rates at the risk and the cost of the supplier and in such
cases the ordering authority has every right to recover the cost and impose penalty as mentioned in Clause 19.
iv) The supplier shall furnish to the purchaser the evidence of bioavailability and/or bio-equivalence for certain
critical drugs will be supplied by the Supplier, if there is any problem in the field and the purchaser requires it
for their satisfaction.
11
17. PAYMENT PROVISIONS
i) No advance payments towards costs of drugs, medicines etc., will be made to the tenderer.
ii) The verification of the bills of the supplier and supplied drugs / Hospital goods would be done by the Stores
in-charge at the warehouse of the Ordering Authorities. On receipt and after verification of the goods, it would
be entered in the stock register. Payment would be made by the Ordering authority.
iii) After receipt of the analytical report regarding quality the payment would be made to the supplier within 30
days of time .
iv) All bills/ Invoices should be raised in triplicate and in the case of excisable Drugs and Medicines, the bills
should be drawn as per Central Excise Rules in the name of the ordering authority .
v) Payments for supply will be considered only after supply of 70% of items of Drugs ordered in the Purchase
Order PROVIDED the supplied items are found to be of standard quality.
vi) If at any time during the period of contract, the price of tendered items is reduced or brought down by any
law or Act of the Central or State Government or by the tenderer himself, the tenderer shall be bound to
inform ordering authority immediately about such reduction in the contracted prices. Ordering authority is
empowered to unilaterally effect such reduction as is necessary in rates in case the tenderer fails to notify or
fails to agree for such reduction of rates.
vii) (a) In case of any enhancement in Excise Duty due to notification of the Government after the date of
submission of tenders and during the tender period, the quantum of additional excise duty so levied will be
allowed to be charged extra as a separate item without any change in the basic of the price structure price of
the Drugs approved under the tender. For claiming the additional cost on account of the increase in Excise
Duty, the tenderer should produce a letter from the concerned Excise authorities for having paid additional
Excise Duty on the goods supplied to ordering authority and also must claim the same in the invoice separately.
Similarly if there is any reduction in the rate of essential drug, as notified by the Govt., after the date of
submission of tender, the quantum of the price to the extent of reduction of essential drug will be deducted
without any change in the basic price of the price structure of the drugs approved under the tender.
(b) In case the successful bidder has been enjoying excise duty exemption on any criteria of Turnover etc., such
bidder will not be allowed to claim excise duty at later point of time, during the tenure of contract, when the
excise duty becomes chargeable on the goods manufactured by them.
18. DEDUCTION IN PAYMENTS:
i) In all supplies, 2% of the contract value shall be deducted towards handling & testing charges.
ii) In all the supplies, 5% of the bill value will be deducted towards security deposit.
iii) If the supply reaches the designated places between 5 PM of the 30th day and 5 PM of 45th day from the
date of purchase order, a liquidated damages will be levied at 0.5% per day for delayed supply between 30th
day and 45th day up to a maximum of 10%, irrespective of the ordering authority having actually suffered any
damage/loss or not, on account of delay in effecting supply.
iv) If there is any unexecuted orders after 5 PM of 45th day from the date of purchase order, the order shall
stand cancelled automatically after levying penalty @ 20% on the value of unexecuted order and such penalty
is recoverable from any amount payable to the supplier or it may lead to forfeiture of security deposit.
12
v) If the supply is received in damaged condition it shall not be accepted. In case of damage in the packing, the
supply will be accepted only after levying penalty on the total value of supply. Further the Performance Security
(SD) would be forfeited with a notice to the supplier.
vi) All the tenderers are required to supply the product with logogram and with prescribed packing
specification. If there is any deviation in these Tender conditions a separate damages will be levied @ 2%
irrespective of the fact that ordering authority had actually suffered any damage/loss or not, without prejudice
the rights of alternative purchase specified in Clause No.13.09
19. QUALITY CONTROL DEDUCTION & OTHER PENALTIES:
i) If the successful tenderer fails to execute the agreement and / or to deposit the required security deposit
within the time specified or withdraws his tender after the intimation of the acceptance of his tender has been
sent to him or owing to any other reasons, he is unable to undertake the contract, his contract will be cancelled
and the Earnest Money deposited by him along with his tender shall stand forfeited by the Tender Inviting
Authority and he will also be liable for all damages sustained by the Tender Inviting Authority apart from
blacklisting the supplier for a period of one year.
ii) If supplied drug fail in quality then supplier will either have to lift the whole lot/batch at their own cost within
30 days and pay the equivalent amount by draft to procure apart from other penalty as per contract. If the lot is
not lifted within 30 days it will be destroyed and all cost, including the cost of destruction will be recovered
from supplier. No payment will be made for the entire rejected/substandard batch of that particular item, even
if the supplies have been consumed in good faith. If the payment has already been made and they fail to pay
the amount then amount will be adjusted from the pending bills for the supplier firm or security deposit. An
additional 10% of the cost of Not of Standard Quality Drugs shall be deducted to meet the cost of handling sub
standard drugs. In no circumstances, request for replacement of sub standard drugs by the supplier shall be
entertained. Further, action will be initiated for blacklisting of the product/firm and legal action as per the rule
and prevailing issued by Drug Controller General (India)
iii) If any items of Drugs / Medicines supplied by the supplier have been partially or wholly used or consumed
after supply and are subsequently found to be in bad odour, unsound, inferior in quality or description or
otherwise faulty or unfit for consumption, then the contract price or prices of such articles or things will be
recovered from the supplier, if payment had already been made to him. In other words the supplier will not be
entitled to any payment whatsoever for Items of drugs found to be of NOT OF STANDARD QUALITY whether
consumed or not consumed and the ordering authority is entitled to deduct the cost of such batch of drugs
from the any amount payable to the tenderer. On the basis of nature of failure, the product /supplier will be
moved for Black Listing.
iv) For supply of drugs of NOT OF STANDARD QUALITY the Controller of Drugs will be informed for initiating
necessary action on the supplier and that product shall be blacklisted and no further supplies accepted from
him till he is legally discharged. The supplier shall also not be eligible to participate in tenders of ordering
authority for supply of such Drugs for a period of five subsequent years.
v) The supplier shall furnish the source of procurement of raw materials utilized in the formulations if required
by ordering authority. Ordering Authority reserves the right to cancel the purchase orders, if the source of
supply is not furnished.
vi) The decision of the ordering authority or any Officer authorized by him with regard to the quality of the
supplied drugs, medicines etc., shall be final and binding.
13
vii) Ordering Authority will be at liberty to terminate without assigning any reasons thereof the contract either
wholly or in part on 30 days notice. The tenderer will not be entitled for any compensation whatsoever in
respect of such termination.
viii) For infringement of the stipulations of the contract or for other justifiable reasons, the contract may be
terminated by the ordering authority, and the supplier shall be liable for all losses sustained by the ordering
authority, in consequence of the termination which may be recovered personally from the supplier or from his
properties, as per rules.
ix) Non performance of any of the contract provisions will disqualify a firm to participate in the tender for the
next five years.
X)(a) In the event of making ALTERNATIVE PURCAHSE, as specified in Clause 13.6, Clause 15.10 and in Clause
16.3 the supplier will be imposed penalty apart from forfeiture of Security Deposit. The excess expenditure over
and above contracted prices incurred by the ordering authority in making such purchases from any other
sources or in the open market or from any other tenderer who has quoted higher rates and other losses
sustained in the process, shall be recovered from the Security Deposit or from any other money due and
become due to the supplier and in the event of such amount being insufficient, the balance will be recovered
personally from the supplier.
(b) Aggrieved by the decision or levy of fine by the Ordering Authority, the supplier can make an appeal with
the concerned Directors. Aggrieved by the decision of the concerned Director, the supplier can take up the
appeal with the Tender Inviting Authority.
xi) In all the above conditions, the decision of the Tender Inviting Authority, viz. Managing Director, Bihar
Medical Services and Infrastructure Corporation Ltd would be final and binding, in case of any dispute regarding
all cases under tender procedure or in any other non-ordinary situation and would be acceptable to all.
xii) All litigations related to the supplier for any defaults will be done by Tender Inviting Authority and his
decision will be final and binding.
20. BLACKLISTING PROCEDURE
The procedure of the ordering authority for blacklisting is in Annexure-X. This procedure is in addition to and
not in derogation of the terms and conditions of the tender documents.
21. REGISTRATION
BMSICL reserve the right to register the technically qualified bidders for future supply of those items for which
they have applied and found qualified on technical grounds as per the rules of registration of BMSICL and
depending upon the requirement only financial bid may be asked for the supply of registered item from those
technically qualified bidders.
22. SAVING CLAUSE No suit, prosecution or any legal proceedings shall lie against Tender Inviting Authority or
any person for anything that is done in good faith or intended to be done in pursuance of tender.
23. JURISDICTION In the event of any dispute arising out of the tender or orders such dispute would be subject
to the jurisdiction of the Court of Patna or Honorable High Court of Bihar.
14
TABLE OF ANNEXURES
--------------------------------------------------------------------------------------------------------------------------------------------------------------
Item No. Topic Page No.
---------------------------------------------------------------------------------------------------------------------------------------------------------------
1. Annexure-I (Sales Tax Clearance Certificate)
2. Annexure-II (Undertaking Form)
3. Annexure-III (Declaration Form)
4. Annexure-IV (Proforma for Performance statement)
5. Annexure-V (Annual Turnover Statement)
6. Annexure-VI (Specification of required drugs and medicines )
7. Annexure-VII (Packing Specification)
8. Annexure-VIII (Contract Agreement form)
9. Annexure-IX (Details of Manufacturing Unit)
10. Annexure-X (Procedure for Blacklisting)
11. Annexure-XI (List of Items Quoted)
12. Annexure-XII (Check List)
13. Annexure XIII (The Landed price)
14. Annexure XIV (Break up Details of landed price)
15. Annexure XV (Performance Security Form)
16. Annexure XVI (Manufacturer Authorization Letter)
15
ANNEXURE-I
Ref. Clause No. 4.1(l)
FORM OR CERTIFICATE OF SALES TAX/VAT VERIFICATION TO BE PRODUCED BY AN APPLICANT FROM THE CONTRACT OR OTHER
PATRONAGE AT THE DISPOSAL OF THE GOVERNMENT OF BIHAR.
(To be filled up by the applicant)
01. Name or style in which the applicant is assessed or assessable to Sales Tax/VAT Addresses or assessment.
02. a. Name and address of all companies, firms or associations or persons in which the applicant is interested in his individual
or fiduciary capacity.
b. Places of business of the applicant (All places of business should be mentioned).
03. The Districts, blocks and divisions in which the applicant is assessed to Sales Tax/VAT (All the places of business should be
furnished).
04. a. Total contract amount or value of patronage received in the preceding three years.
2009- 2010
2010- 2011
2011- 2012
b. Particulars of Sales - Tax/VAT for the preceding three years.
Year Total T.O. be Total Tax assessed Total Tax paid Balance due Reasons for balance
assessed
(Rs.) (Rs.)
(Rs.) (Rs.) (Rs.)
2009- 2010
2010- 2011
2011- 2012
16
c. If there has been no assessment in any year, whether returns were submitted any, if there were, the division in which the
returns were sent.
d. Whether any penal action or proceeding for the recovery of Sales Tax/VAT is pending.
e. The name and address of Branches if any:
I declare that the above information is correct and complete to the best of my knowledge and belief.
Signature of applicant:
Address:
Date:
(To be filled up by the Assessing authority) : OPTIONAL
In my opinion, the applicant mentioned above has been/ has not been/ doing everything possible to pay the tax demands promptly
and regularly and to facilitate the completion of pending proceedings.
Date Seal : Deputy / Asst. Commercial Tax – Officer
Deputy Asst.
NOTE: A separate certificate should be obtained in respect of each of the place of business of the applicant from the Deputy Commercial
Tax Officer or Assistant Commercial Tax Officer having jurisdiction over that place.
17
ANNEXURE-II
Ref. Clause No. 4.1(n) & 14.1
UNDERTAKING
I do hereby undertake that I will supply the Drugs /………………………….. as per the designs/specifications given in enclosures to
this Annexure and as per the instructions given in this regard.
Signature of the bidder
Name in capital letters with Designation & official seal
Attested by Notary Public.
18
ENCLOSEURE-I TO ANNEXURE-II – REFER CLAUSE NO. 14
DESIGN FOR LOGOGRAM
TABLET/INJECTION/SURGICAL/SUTURE
m
m
One side
BG
Another side
DESIGN FOR STRIP ALONG WITH THE MATTER TO BE PRINTED -Description of the Tablet as per pharmacopoeia
" For Bihar Govt. Not for sale "
INJECTIONS
Injection in ampoule form should be supplied in Double constructed neck ampoules with the label bearing the words "Bihar Govt. Not for
sale" overprinted and the following logogram which will distinguish from the normal trade packing.
M
BG
PG
The vials should be supplied with aluminum seals containing

G the following logogram.
BG
G
19
ENCLOSURE-II TO ANNEXURE-II
Refer Clause no. 14
SPECIMEN LABEL FOR OUTER CARTON

BIHAR GOVT. SUPPLY
NOT FOR SALE
~~~~~~~~~~~~~~~~~~~~~
L.S.C.S.KIT
~~~~~~~~~~~~~~~~~~~~~
Sl.No. Name of the Batch No. Mfg. Packing Quantity Manufactured

item/drug date/expiry by
date
Net Weight: …… Kg.
Name of the supplier
20
ANNEXURE-III
Ref. Clause No. 4.1. (j)
DECLARATION
I/We M/s._____________________ represented by its Proprietor / Managing Partner / Managing Director having its
Registered Office at ________________________________________________and its Factory Premises at
____________________________________________________ do declare that I/We have carefully read all the conditions of tender
No. ------------ for supply of …………… floated by the Managing Director, Bihar Medical Services and Infrastructure Corporation Ltd.
(BMSICL) and accepts all conditions of Tender document.
I/We declare that my manufacturer posses the valid licence and GMP Certificate as per revised Schedule-‘M’ issued by the
Competent Authority and complies and continue to comply with the conditions laid in Schedule M of Drugs & Cosmetics Act, 1940
and the Rules made there under. I/We undertake full gurrantee/warrantee for the of the items of kit
I/We agree that the Purchaser forfeiting our Bid security and or Performance Security Deposit and blacklisting me/us for a
period of 5 years if, any information furnished by us proved to be false at the time of inspection and not complying the conditions as
per Schedule M of the said Act.
Signature:
Seal
Name & Address :

To be attested by the Notary.
21
Enclosure to Annexure – III
Refer Clause 4.1
Declaration for Compliance of cGMP
01. Name and Address of the Firm :
02. Name of Proprietor / Partner / Director :
03. Name and Designation of Person Present :
04. GMP Certificate as per Revised Schedule “M”
05. Details of Licenses Held With Validity :
06. Number of Workers Employed :female : male :
07. Whether Workers Provided with Uniform : Yes / No
08. Whether Medical Examination done for the Workers : Yes / No
09. Hygienic Condition: Satisfactory / Not Satisfactory
(I) Surrounding : Satisfactory / Not Satisfactory
(II) Production Areas : Satisfactory / Not Satisfactory
22
(III) Other Areas : Satisfactory / Not Satisfactory
10. Provision for Disposal of Waste : Yes / No
11. Heating System : Yes / No
12. Whether Benches provided in all working areas : Yes / No
13. Water Supply
(A) Source :
(B) Storage Condition : Satisfactory / Not Satisfactory
(C) Testing (With reference to Pathogenic Organisms) : Yes / No
(D) Cleaning Schedule in Water Supply System with Proper Records : Yes / No
(E) Type of Machinery installed as to Semi-automatic or Fully Automatic plant for water purification system along with cost and
whether this is working, and if so the flow rate of Pharmaceutical water to meet the requirements of preparation
:
14. Air handling system along with list of machine and cost of the unit, separately for sterile and non sterile preparation
:
15. Whether the pollution control clearance is valid for Air and Water and if so the period upto which valid (copy of the
certificate to be enclosed) :
16. Raw Material Storage Area
(I) Quarantine : Provided / Not Provided
23
(II) Passed Materials : Provided / Not Provided
(III) Rejected Materials : Provided / Not Provided
17. Finished Product Storage Area
(I ) Quarantine : Provided / Not Provided
(II) Released Material : Provided / Not Provided
18. Details of Technical Staff
Name Qualification Experience
For Manufacturing:
For Testing:
19. Testing Facilities (List of Equipments to be furnished separately in the format to meet the bench mark vide Annexure)
Chemical Method : Yes / No
Instrumental : Yes / No
(Type of Instrument provided as indicated in Annexure)
Biological : Yes / No
Micro Biological : Yes / No
24
Animal Testing : Yes / No
20. Remarks
(A) Whether Products Quoted to BMSICL are Endorsed in the License: Yes / No
(B) Whether the drugs quoted to BMSICL have been Manufactured Earlier (Last 3 Years) :Yes/No
If Yes, Details Like
Sl.N Date of Manufacture Name of the Drug Batch No. Batch Size Date of
o Release
Production Capacity (Section Wise)
PRODUCTION CAPACITY:
Tablet Section
Type of Equipments No. of Production Capacity of all No. of shift Production Capacity
Equipments the Equipments in allotted for BMSICL
column 2
(1)
(2) per shift (3) (5)
(4)
Planetary mixer
Fluidized bed drier
Tray drier
Mechanical shifter
Multi mill
Tablet compression machine
1) With ________ number of station
25
Type of Equipments No. of Production Capacity of all No. of shift Production Capacity
Equipments the Equipments in allotted for BMSICL
column 2
(1)
(2) per shift (3) (5)
(4)
2) With _________ number of station
Coating pan.
Blister Packing machine
Strip packing machine
Capsule Section
Type of Equipments No. of Production Capacity of all No of shift Production

Equipments the Equipments in column Capacity allotted
(1) 2 per shift for BMSICL
(2) (4)
(3) (5)
Double cone blender
Automatic capsule filling machine
Semi automatic Capsule filling machine
Hand filling machine
Blister packing machine
Strip packing machine
Parenteral Section

Equipments the Equipments in column Capacity
(1) 2 per shift (4) allotted for
(2) BMSICL (5)
(3)
Small volume Parenteral
Mixing Vessel
Laminar Flow unit
26
Equipments the Equipments in column Capacity
(1) 2 per shift (4) allotted for
(2) BMSICL (5)
(3)
Filtration unit
Ampoule filling machine
(with No of head)
Vial filling Machine
(with No of head)
Vial sealing machine
Powder filling machine
Autoclave for terminal Sterilization
Ampoule labeling machine
Vials labeling machine
Large Volume Parenteral Section
Type of Equipments No. of Production No of shift Production

Equipments Capacity of all the Capacity
Equipments in allotted for
(1) (2) column 2 per (4) BMSICL (5)
shift (3)
Mixing Vessel
Filtration unit
Filling Machine Autoclave for terminal

Sterilization
Labeling
Machine
Ointment / Cream
Type of Equipments No. of Production Capacity of all the No of Production Capacity allotted for
Equipments Equipments in column 2 per shift shift NMSICL
(1)
(2) (3) (4) (5)
Stream jacket vessel for mixing
Ointment/cream filling machine
27
Liquid Section
Type of Equipments No. of Production Capacity of all the No of shift Production Capacity
Equipm Equipments in column 2 per allotted for BMSICL
ents shift (4)
(1) (5)
(2) (3)
Bottle washing machine
SS tank with capacity
Filter press
Colloidal mill
Bottle Filling Machine
Labeling Machine
External Preparation
Type of Equipments No. of Production Capacity of all the No of shift Production Capacity
Equipments Equipments in column 2 per allotted for BMSICL (5)
(1) shift (3) (4)
(2)
Mixing Vessel
Filling machine
Labeling machine
(D) Any, Not Of Standard Quality : Yes / No
Reports Of Product Quoted/
(If Not, Nil Statement)
(E) Any Prosecution After : Yes / No
Submission of Tender Documents.
(If Not, Nil Statement)
(F) Chances Of Cross Contamination : Yes / No
28
at Raw Materials/In Process/
Finished Product Stages And Steps/ Facilities
(G) Validation of Equipments done : Yes / No
(H) Cleaning Schedule
(I) For Premises :
(II) For Equipments :
(I) Adverse Reaction, If Any and :
Reported
Sl. No. Description Remarks
1 Whether any drug(s) manufactured by the tenderer has

/ have been recalled during last five years? If yes given
details
2 What are the results of investigations on the recalled

drug(s)?
3 What action have been taken to prevent recurrence of

recall of drug(s) on that particular account?
(J) Complaints Received If Any :
and Steps taken.
Sl. No. Description Remarks
1 Whether any drug(s) manufactured by the tenderer has / have been

recalled during last five years? If yes given details
2 What are the results of investigations on the recalled drug(s)?
3 What action have been taken to prevent recurrence of recall of drug(s)

on that particular account?
29
Instruments Provided in the Quality Control Lab
Sl.No. Name of the Instruments No. of Instruments Cost of Whether it is in

Instruments working condition
(2) (3) (4) (5)

(1)
1 Analytical Balance
2 Infra Red Spectrometer
3 Karl Fisher Tritator
4 Melting Point
5 Brookfield Viscometer
6 Polarimeter
7 Autoclave
8 Refractometer
9 Sampling Booth
10 UV-Vis Spectrometer
11 HPLC
12 Muffle Furnace
13 Fuming Cupboard
14 Micrometer
15 Dissolution Tester
16 Disintegration Tester
17 Friability Tester
18 Vernier Calipers
19 IR Balance
20 Hardness Tester
21 Leak Test Apparatus
22 Laminar Air Flow
23 BOD Incubator
24 Vacuum oven
30
Sl.No. Name of the Instruments No. of Instruments Cost of Whether it is in
Instruments working condition
(2) (3) (4) (5)

(1)
25 Bulk Density Apparatus
26 Water Activity Meter
27 Anaerobic System
28 Gas Chromatograph
29 LAL Kit
30 Sterility Test Kit
31 Particle Counter
32 Air Sampler
33 Flame Photometer
34 Tap Density Tester
Signature and Seal of Proprietor / Partner / Director
To be attested by the Notary.
31
ANNEXURE-IV
Ref. Clause No. 4 .1(f)
PROFORMA FOR MARKET STANDING CERTIFICATE
(FOR A PERIOD OF LAST 3 YEARS)
Name of firm
Sl.No. Name of The Product Quantity Manufactured (and No. of batch) Name and Address of Purchaser
Year1 Year 2 Year 3
32
Annexure-V
Ref. Clause. 4.1. (k)
ANNUAL TURN OVER STATEMENT
The Annual Turnover of M/.s__________________________(bidder) for the past three years are given below and certified that the
statement is true and correct:
___________________________________________________________________________
Sl.No. Year Turnover in Lakhs (Rs)

___________________________________________________________________________
1. 2009-10
2. 20010-11
3. 2011-12
_________________________________________________________________________
Total - Rs. _________________ Lakhs.
___________________________________________________________________________
Average annual turnover :
Signature of Auditor/ Chartered Accountant
(Name in Capital)
Seal
Date
33
ANNEXURE-VI
Ref Clause No. 9.2
List of Drugs required
Sl. Name of the Item /drug Dosage Form Unit Specifications Approx Remarks, if
No tendered any
quantity in No.
Note:- The Quantity may increase or decrease as per Clause No. 9.2
1. Every Consignment of Blood and related products should be certified to be (a) AIDS Free (b) Hepatitis B Free
2. Ointments should be packed in liquidized Aluminium Tubes.
3. Small Tablets packed in blisters should be packed to facilitate easy removal of the tablet without breaking / crushing. Specification of
outer cartons are as given in the Schedule (Annexure-VII)
4. In case of any conflict between Carton specifications and packets per carton specification (Last column of this table), the specification of
the packets / carton shall prevail. All tablets should have a score line.
5. All plastic containers should be made of virgin grade plastics.
6. All plastic jars above 450Gms / ml should carry an inner plastic lid.
7. Strips of Aluminium foils refer to gauge 04.
8. Aluminium foils as back material for blisters refer to gauge 025.
9. The rigid PVC used in blister packing should be of not less than 250 micron.
10. All glass bottles should be new neutral glass.
11. All tablets should have a score line.
12. The strips shall be aluminium strip / blisters with aluminium foil back.
13. Injection in vials should have a snap of seals.
14. The strips shall be aluminium strip / blisters with aluminium foil back
34
List of Drugs & Medicine
Estimated
Consumption
Sl. Drug Name Dosage Form Unit Specification
Quantity (in
Nos.)
100ml
1 5-Fluorouracil Injection 250 mg- 5 ml Vial
vial 1000
A
1 Aceclofenac Tab 10x10 100 mg 1000
2 Acetyl Salicylic Acid (Aspirin) Tab 14x10 75mg

1000
1mg/ml - 1ml
3 Adrenaline Bitartrate Inj 1ml amp.
Ampoules 1000
Adrenochrome mono semi
4 Inj 2ml amp. 1mg/ml- 2ml amp.
carbazone 1000
5 Albendazole Tab 10x10 400 mg. 7322769
6 Albendazole Suspension 10ml 10 ml (200 mg/5 ml) 797885
500ml
7 Albumin Injection 5%
bottle 1000
500ml
8 Albumin Injection 20%
bottle 1000
9 Alprazolam Tab 10x10 0.25mg 163875
10 Alprazolam Tab 10x10 0.5mg 18688
11 Amikacin Injection 2ml vial Containing 500mg 44635
14 Amino acid Solution 10279
15 Aminophylline Injection 10ml vial 25 mg /ml. 1000
16 Amitriptyline Tablets 10x10 25 mg. 311363
17 Amlodipine Tablets 10x10 5mg 183641
18 Amoxicillin Cap 10x10 500mg 9893881
60ml
19 Amoxicillin+Clavulanic Acid Suspension 125mg+31.25mg/5ml
bottle 1000
Each vial containing
Amoxicillin+Clavulanic Acid
20 Injection vial Amoxycillin-
(Inj)
1000mg, + 200mg 1000
Amoxicillin+Clavulanic Acid
21 Tablets 10x10 500mg + 125mg
(Tab) 4914885
60 ml syrup. Each 5
ml containing
22 Amoxicillin+Cloxacillin Dry Syrup 60ml Amoxycillin-125 mg
and Cloxacillin 125
mg 526413
23 Amoxycillin Cap 10x10 250 mg 18199469
24 Amoxycillin Cap 10x10 500 mg 9893881
35
60ml
25 Amoxycillin Kit Tablets 125mg DT
bottle 7961450
26 Ampicillin Injection vial 500mg vial 93438
Containing ampicillin-
27 Ampicillin+Cloxacillin Injection vial 500mg & cloxacilin-
500mg 398475
Containing ampicillin-
28 Ampicillin+Cloxacillin Injection vial 250mg & cloxacilin-
250mg 811958
Tablet Containing:
Dried Aluminium
Hydroxide Gel-250,
29 Antacid Tablets Tablets 10x10
Mag Hydroxide-
250mg, Activated
Dimethicon 50mg 5327879
Anti Hemophilic Factor - Factor
30 Injection vial Dried
VIII 1000
31 Anti scorpion Venom Injection 1000
Anti-D Immunoglobulin
32 Injection 250mg
(Human) 1000
Anti-D Immunoglobulin
33 Injection 300mg
(Human) 1000
Polyvalent (Liquid)
34 Antisnake Venom Injection Vial
10ml IP 1000
Antitetanus Human
35 Injection 250 IU
Immunoglobin 1000
Antitetanus Human
36 Injection 1000 IU
Immunoglobin 1000
500ml
37 Anaesthetic Ether Inhalation 500 ml bottle
bottle 1000
38 Artesunate Injection vial 60 mg per vial 1000
39 Artesunate Tablet 10x10 50 mg 1000
40 Atenolol Tablets 14x10 25mg 441313
41 Atenolol Tablets 14x10 50mg 608063
0.6mg/ml - 1ml
42 Atropine Sulphate Injection 1ml amp.
Ampoule 297304
43 Atropine Sulphate Drops 1ml amp. 1% 1000
44 Azithromycin Suspension 100mg/5ml 1000
B
15gm
1 Betamethasone Dipropionate Cream 0.05% 15gm tube.
tube 1000
containing
2 Bupivacaine HCl Injection 1ml amp. Bupivacaine- 5mg/ml-
20ml vial 1000
36
Bupivacaine
Hydrochloride-5mg +
3 Bupivacaine Hydrochloride Injection 4ml amp. Dextrose
Monohydrate-
80mg/ml-4ml Inj. 1000
4 Butorphanol tartrate Injection 1mg/ml 1000
5 Butorphanol tartrate Injection 2mg/ml 1000
C
Containing Elemental
1 Calcium Tablets 10x10 calcium-500mgand
Vit D3-250I.U. 13511206
Containing Elemental
2 Calcium Tablets 10x10
calcium-250mg 1000
3 Calcium Gluconate Injection amp/vial 100mg/ml 17250
4 Carbamazepine Syrup 20mg/ml 1000
5 Carbamazepine Tablet 10x10 200mg 59298
6 Carbamazepine Tablet 10x10 100mg 16963
30 ml- each 5 ml
7 Cefadroxyl Surpension 30ml containing cefadroxil-
125mg suspension 49553
8 Cefadroxyl Tablets 10x10 250 mg 575001
9 Cefadroxyl Tablets 10x10 500 mg 460000
10 Cefixime Dispersible Tablet 10x10 50mg D.T.

1000
30ml 50 mg per 5 ml - 30
11 Cefixime Dry Syrup
bottle ml pack 21563
12 Cefixime Tablets 10x10 100mg 718750
13 Cefixime Tablets 10x10 200mg 734800
14 Cefixime Tablets 10x10 400 mg 371163
15 Cefotaxime Injection vial 500mg vial 329619
17 Cefotaxime Injection vial 1gm vial 555954
19 Ceftazidime Injection vial 500mg vial 67275
20 Ceftazidime Injection vial 250mg vial 21563
21 Ceftazidime Injection vial 1g vial 88119
22 Ceftriaxone Injection vial 1g vial 107813
23 Ceftriaxone Injection vial 500mg vial 16244
24 Ceftriaxone Injection vial 250mg vial 2588
25 Ceftriaxone+Salbactum Injection vial 500mg+250mg 1000
26 Ceftriaxone+Salbactum Injection vial 250mg+250mg 1000
27 Cefuroxime DT 10x10 125mg D.T. 1000
20% (conc. for
28 Cetrimide Solution Jar
dilution) 1000
29 Cetrizine Tablets 10x10 10mg 1250
37
5mg/5ml- 30ml syrup
30 Cetrizine Suspension 30ml
bottle 191044
Pack of
Chloramphenicol 1% Eye
31 Ointments/Aplicaps 50 1% Eye Applicacaps
Applicacaps
Applicaps 1000
Pack of
Chloramphenicol 0. 4% Eye
32 Ointments/Aplicaps 50 0.4% Eye Applicacaps
Applicacaps
Applicaps 1000
Chlorinated Lime Water (EC
33 Solution 1.25mg
Lotion) 1000
34 Chloroquine Phosphate Tablets 150mg 150mg Base 1000
35 Chloroquine Phosphate Syrup 50mg 50mg/5ml 1000
36 Chlorpheniramine Maleate Tablets 10x10 4mg tab

332063
37 Chlorpheniramine Maleate Injection 10ml vial 10mg/ml- 10 ml vial

1000
38 Ciprofloxacin Tablets 10x10 250mg 21094439
39 Ciprofloxacin Tablets 10x10 500mg 28671225
40 Ciprofloxacin HCl Injection 100ml IV 200mg/100ml 175479
41 Ciprofloxacin Eye/Ear Drops Drop 5ml vial 0.3%w/v 5ml vial.

192194
2mnl
42 Clindamycin Injection 150mg/ml-2ml amp.
amp. 1000
43 Clonazepam Tablets 10x10 0.5mg 57500
44 Clotrimazole Pessaries 1's 100mg 164105
45 Clotrimazole Pessaries 1's 200mg 1000
Trimethoprim I.P. -
80mg
46 Co-Trimoxazole Tablets 10x10
Sulphamethoxazole
I.P. 400mg 1000
Trimethoprim I.P. -
40mg
47 Co-Trimoxazole Tablets 10x10
Sulphamethoxazole
I.P. 200mg 1000
100 ml pack. Each 5

ml containing at least
- Diphenhydramine
Hydrochloride IP-
48 Cough Expectorant Syrup 100ml 14.08mg, Amonium
Chloride IP- 138 mg,
Sodium Citrate-IP
57.03 mg, Menthol-
IP-2.5mg
4407346
38
100 ml pack. Each 5
ml containing at least-
dextromethorpham
hydrobromide- 10mg,
pseudoephedrine
49 Cough Suppressant Syrup 100ml
hydrochloride-
12.5mg &
chlorpheniramine
maleate- 2mg,
menthol-1.5mg 1000
50 Cyclophosphamide Injection vial 200 mg vial 1000
51 Cyclophosphamide Injection vial 500 mg vial 1000
D
Inj. - 4mg/ml- 2ml
1 Dexamethasone Injection 2ml vial
vial 685839
Inj.- 4mg/ml- 10ml
2 Dexamethasone Injection 10ml vial
Vial 146970
3 5% Dextrose Infusion 500ml 500 ml bottle 378796
4 10% Dextrose Infusion 500ml 501 ml bottle 109826
5 50% Dextrose Injection 25ml 25 ml ampoule 1000
5% Dextrose + 0.9% Sodium
6 IV 500ml 500 ml bottle
Chloride Inj. 1438
10% Dextrose + 0.9% Sodium
7 IV 500ml 50 ml bottle
Chloride Inj. 1000
8 Diazepam Tablets 10x10 Tablet- 5mg/ml 365125
9 Diazepam Injection 2ml Amp 2ml amps (5mg/ml) 381455
10 Diazepam Injection 2mg 2mg/ml 1000
11 Diclofenac Tablets 10x10 Tablet- 50mg 29484635
Inj.- 25mg/ml - 3ml
12 Diclofenac Injection 3ml Amp
Ampoules 1394126
30gm
13 Diclofenac Gel 1 %w/w - 30gm Tube
tube 179144
14 Dicyclomine HCl Tablets 10x10 10 mg 4371438
15 Dicyclomine HCl Injection 2ml 20 mg/2ml ampoule 1000
16 Dicyclomine HCl+Paracetamol Tablets 10x10 10mg+500mg

1000
17 Dicyclomine HCl+Paracetamol Tablets 10x10 20mg+500mg

1000
18 Diethylcarbamazine Citrate Tablets 10x10 50mg

1000
250 mg/5ml- 20ml
19 Dobutamine Injection 5ml amp.
vial & 5ml amp. 1000
200mg/ml- 5ml
20 Dopamine HCl Injection 5ml amp.
ampoules 1000
21 Doxycycline Capsules 10x10 100mg 2112205
20mg/ml-2 ml
22 Drotaverine Injection 2ml amp.
ampoule 1438
E
39
30mg/ml - 1 ml
1 Ephedrine Injection 1ml amp.
ampoule 1000
2 Esomeprazole Injection vial 40mg 1000
3 Ether Anaesthetic Inhalation 500ml 500ml bottle 1000
Each 2 ml contains
Etophylin - 169.40mg
4 Etophylline +Theophylline Injection 2ml amp. & Theophylin
50.6mg.- 2ml
ampoule 1000
Each Tab contains
5 Etophylline +Theophylline Tablets 10x10 Theophylline23 mg +
Ethophyline 77 mg 1000
F
1 Fluconazole Tablets 10x10 150mg. 534750
2 Fluoxetine HCl Capsules 10x10 20mg. 1585491
3 Framycetin Hydrochloride Ointment 5gm Tube 0.5% 5gm

1000
Inj.- 10mg/ml- 2ml
4 Frusemide Injection 2ml Amp
Ampoules 54194
5 Frusemide Tablets 10x10 Tablet 40mg 44563
10gm
6 Fusidic Acid (Sodium Fusidate) Ointment 20mg/gm- 10gm tube
tube 69000
G
100ml Lotion 1% 100ml
1 Gamma Benzene Hexachloride Lotion
bottle bottle. 304233
5 ml (contains 0.3%
2 Gentamicin - Ear/Eye Drop Drop/Injection 5ml vial
w/v Gentamicin) 1403590
3 Gentamicin Injection 40mg 40mg/ml 1000
0.2 mg/ml- 1 ml
4 Glycopyrrolate Injection 1ml amp.
ampoule 1000
H
5 mg/ml- 1 ml
1 Haloperidol Injection 1ml amp.
ampoule 1000
250ml
2 Halothane Inhalation 250 ml bottle
bottle 1000
Inj. -5ml vial.
3 Heparin Sodium Injection 5ml vial Containing- 5000
I.U./ml. 1000
Inj. -5ml vial.
4 Heparin Sodium Injection 1ml vial Containing- 1000
I.U./ml. 1000
5 Human Normal Immunoglobulin Injection vial

1000
6 Hyalouronidase Injection vial 1500 I.U. 1000
7 Hydrochlorothiazide Tablets 10x10 50 mg 1000
8 Hydrochlorothiazide Tablets 10x10 25 mg 1000
40
Hydrocortisone Sodium
9 Injection vial Inj. 100mg
Succinate 37354
I
10ml vial Inj.
1 Insulin Injection (Soluble) Injection 10ml Vial
(40IU/ml) 1000
Each tab contains
Elemental Iron (as
2 Iron Folic Acid Tablets Small 10x10 carbonyl Iron) 20 mg,
Folic Acid
.I.P.100mcg.
9303500
Each tab contains
Elemental Iron (as
3 Iron Folic Acid Tablets Large 10x10 carbonyl Iron) 100
mg, Folic Acid .0.5
mg. 17564813
Each 5ml containing
200ml elemental iron-
4 Iron Folic Acid Syrup
bottle 100mg,Folic Acid
0.5mg, 1000
500ml
5 Isolyte (M,G,P) Infusion 500ml bottle
bottle 1000
6 Isosorbide Dinitrate Tablets 10x10 10mg 344281
9 Isosorbide-5-mononitrate Tablets 10x10 Tab-10mg 1000
10 Isosorbide-5-mononitrate Tablets 10x10 Tab-20mg 1000
11 Isoxsuprine Hydrochloride Tablets 10x10 10mg.

301875
5 mg/ml- 2 ml
12 Isoxsuprine Hydrochloride Injection 2ml amp.
ampoules 1000
K
Inj.- 50mg/ml- 2ml
1 Ketamine Hydrochloride Injection 2ml vial
Vial 1000
Inj.- 10mg/ml- 2ml
2 Ketamine Hydrochloride Injection 2ml amp.
Vial 1000
L
30ml 2.5mg/5ml- 30ml
1 Levocetrizine Suspension
bottle bottle 1000
Lignocaine Hcl- 53.5
2 Lignocaine Hydrochloride Heavy 2ml amp. mg=5% + Dextrose-
75mg - 2 ml ampoule 1000
3 Lignocaine Hydrochloride Jelly 2ml amp. 2%, 30gm 1000
100ml
4 Lignocaine Hydrochloride Viscous 2%- 100ml
vial 1000
5 Lignocaine Hydrochloride Injection 30ml vial 1%- 30ml vial 1000
6 Lignocaine Hydrochloride Injection 30ml vial 2%- 30ml vial 9560
41
Each ml contains
Lignocaine
Lignocaine
7 Injection 30ml vial hydrochloride20mg
Hydrochloride+Adrenaline
and Adrenaline .5
mcg. - 30ml vial
1000
8 Lorazepam Injection 2ml amp 2mg/ml-2ml amp 1000
9 Lysol (Cresol with soap) Solution 1 Litre Jar 1 Litre (50% + 50%) 1670
10 Lysol (Cresol with soap) Solution 5 Litre Jar 5 Litre (50% + 50%) 1250
M
50% Sol. 5 ml amp.
1 Magnesium Sulphate Injection 5ml amp.
(0.5 gms/ml.) Inj. 50845
100ml
2 Mannitol Injection 20% w/v- 100ml.
bottle 42214
3 Mefenamic acid Tablets 10x10 250mg tab 1000
4 Mephentermine Injection 10ml Vial 30 mg/ml- 10 ml vial 1000
5 Meropenem Injection vial 500mg 1000
6 Meropenem Injection vial 1000mg 1000
7 Methotrexate Tablets 10x10 2.5 mg tablets 1000
50 mg/2ml - 2 ml
8 Methotrexate Injection 2ml amp.
ampoule 1000
9 Methotrexate Injection 25mg 25 mg/ml 1000
10 Methyl Ergometrine Tablets 10x10 0.125 mg tab. 4900438
0.2mg per ml. - 1 ml
11 Methyl Ergometrine Injection 1ml amp.
ampoule 620138
(40 mg/ml) for intra
12 Methylprednisolone Injection 2ml Amp articular Inj. 2 ml
ampoules 14375.00
13 Metoclopramide Tablets 10x10 10mg Tab 3561263
5 mg/ml- 2 ml
14 Metoclopramide Injection 2ml Amp
ampoules 1496913
15 Metronidazole Tablets 10x10 Tablet- 400mg 11795981
16 Metronidazole Infusion 100ml Inj. 500mg/100ml 261789
15gm 15 gm Tube (contains
17 Miconazole Ointment or Cream
tube 2% miconazole) 228131
18 Micronised Progesterone Tablets 10x10 100 mg 1000
19 Micronised Progesterone Tablets 10x10 200 mg 1000
20 Midazolam Injection 5ml vial 1mg/ml, 5ml vial 1438
21 Midazolam Injection 5mg 5mg/ml, 1000
22 Misoprostol Tablets 10x10 100 mcg. 1000
23 Misoprostol Tablets 10x10 200 mcg. 1000
24 Moxifloxacin Eye/Ear Drops 0.5% w/v

1000
42
Containing- Vit A, Vit
D, Vit C, Vit B1, B2,
B6, B12,
25 Multivitamins Drop/Syrup 15ml Niacinemecle and D-
Panthenol- as per
schedule V of Drug &
Cosmetics Rules 1995
1000
N
1 Neostigmine Injection 1ml amp. 0.5mg/ml-1ml amp. 6480
2 Nikethamide Injection Amp/vial 25% w/v 1000
4 mg/2ml- 2 ml
3 Noradrenalin Injection 2ml Amp
ampoule 1000
4 Norethisterone Tablets 10x10 5mg tab 1000
500ml Sodium Chloride-
5 Normal Saline Injection
bottle 0.9% - 500 ml Bottle 214625
500ml 0.45% (N/2) 500ml
bottle Bottle 1000
100ml Sodium Chloride-
bottle 0.9% - 100 ml Bottle 11500
O
1 Ofloxacin Syrup 30ml 50mg/ml 1000
2 Ofloxacin IV Infusion 100ml Inj. 200mg/100ml 28750
10ml. containing Ofloxacin
3 Ofloxacin (Eye/ear drop) Drop
Vial 0.3% w/v - 10ml. Vial 490898
30 ml each 5 ml
containing ofloxacin-
4 Ofloxacin+ Ornidazole Suspension 30ml
50 mg ornidazole-125
mg 2650823
5 Ondansetron Tablets 10x10 4mg 2750513
6 Ondansetron Tablets 10x10 8mg 1253500
Containing
30ml
7 Ondansetron Syrup Ondansetron-2mg per
phial
5ml- 30ml phial 71221
8 Ondansetron Injection 2mg Inj. 2mg/ml Ampoule 1000
20.5 gram packet
Each sachets contains-
Dextrose (anhydrous)
- 13.5 gm, Sodium
Powder for 20.5 gram
9 Oral Rehydration Salts Chloride - 2.6 gm
Solution packet
Potassium Chloride-
1.5 gm Sodium
Citrate - 2.9 gm
Excipients - 0.5 gm 2329075
5 I.U./ml-1ml
10 Oxytocin Injection 1ml amp.
ampoules. 401350
10 I.U./ml-1ml
11 Oxytocin Injection 1ml amp.
ampoules. 1000
43
P
1 Pantoprazole Injection vial Inj. 40mg/ Vial 426938
2 Paracetamol Tablets 10x10 Tab- 500mg 63370239
3 Paracetamol Injection 150mg 150mg/ml 1000
Syrup- 125mg/5ml-
4 Paracetamol Syrup 60ml
60ml 1419963
5 Paracetamol Drops 15ml 50mg/ml-15ml drops 1000
30 mg/ml- 1 ml
6 Pentazocine Injection 1ml amp.
ampoule 183699
22.75 mg/ml. - 2 ml
7 Pheniramine Maleate Injection 2ml vial
vial 7188
60ml
8 Phenobarbitone Suspension 20mg/5ml-60ml bottle
bottle 1000
200 mg/ml-1ml
9 Phenobarbitone Injection 1ml amp.
injection 1000
100ml
10 Phenytoin Sodium Syrup 25mg/ml-100ml
bottle 1000
11 Phenytoin Sodium Injection 2ml amp 50mg/ml.- 2ml Amp. 1000
12 Pilocarpine Drops 1ml amp. 0.5%- 1ml ampoule 1000
vial containing
Peperacilin Sodium -
13 Piperacellin+Tazobactum Injection vial
4 gm & Tazobactam-
500 mg 1000
vial containing
Peperacilin Sodium -
14 Piperacellin+Tazobactum Injection vial
2 gm & Tazobactam-
250 mg 1000
100ml (contains : 5%
15 Povidone Iodine Solution 100ml
w/v Povidone Iodine) 151836
5% ointment-15gm
16 Povidone Iodine Ointment 15gm
Tube 331975
17 Povidone Iodine Ointment 10% Ointment 1000
18 Pralidoxine Chloride (2-PAM) Injection 20ml vial 25mg/ml-20ml vial

1000
19 Prednisolone Tablets 10x10 5mg 396031
20 Prednisolone Tablets 10x10 10mg 175375
60ml 5mg per 5 ml - 60 ml
21 Promethazine Syrup
pack pack 1000
22 Propofol Injection 10ml vial 1% - 10 ml vial 1000
23 Propofol Injection 10ml vial 2% - 10ml vial 1000
24 Psoralen (Methoxsalen) Lotion 0.75% 1000
25 Psoralen (Methoxsalen) Tablets 10x10 10 mg 1000
26 Psoralen (Methoxsalen) Tablets 10x10 5mg 1000
R
1 Rabeprazole Tablets 10x10 20 mg tab 1000
44
2 Rabeprazole Tablets 10x10 10mg tab 1000
3 Rabeprazole Hydrocholoride Injection vial 20mg vial

1000
4 Rabies Immunoglobulin Injection 1ml 150 IU/ml 1000
0.5ml/1ml vial
0.5ml/1ml containing 2.5 I.U
5 Rabies Vaccine (ARV) Injection
vial (Intramuscular and
Intradermal) 706504
6 Ranitidine Tablets 10x10 150mg 3732325
500ml
7 Ringer Lactate Solution 500ml bottle
bottle 1000
S
1 Salbutamol Sulphate Tablets 10x10 4mg 1000
2 Salbutamol Sulphate Tablets 10x10 2mg 1000
containing not less
than salbutamol-1mg
Salbutamol 100ml
3 Syrup theophyllin/choline
Sulphate+Theophylline bottle
theophylline-
50mg/100ml bottle
1000
15 gm Tube (contains
15gm
4 Silver Sulphadiazine Cream 1% Silver
tube
Sulphadiazine) 754561
25ml
5 Sodium Bicarbonate Injection 7.5% w/v - 25 ml inj.
Amp 6096
Containing 200mg of
100ml Sodium
6 Sodium Valproate Syrup
bottle Valporate/5ml- 100ml
bottle 1000
7 Sodium Valproate Tablets 10x10 200mg 1000
8 Sodium Valproate Tablets 10x10 500mg 1000
9 Spironolactone Tablets 10x10 50mg 17869
10 Spironolactone Tablets 10x10 100 mg 1000
11 Streptokinase Injection vial 7.5 lac I.U. - per vial 1000
12 Streptokinase Injection vial 15 lac I.U.- per vial 1000
Contaning
Sulphadoxine-500 mg
13 Sulfadoxine +Pyrimethamine Tablets 10x10
& Pyrimethamine-25
mg 431250
T
1 Teicoplanin Injection vial 200mg vial 1000
2 Teicoplanin Injection vial 400mg vial 1000
3 Tetanus Toxoid Injection vial vial 1000
4 Thiopentone Sodium Injection vial 1gm vial 1000
5 Thiopentone Sodium Injection 0.5g vial 1000
45
Inj. 50mg/ 1ml
6 Tramadol HCl Injection 1ml Amp
Ampoule. 51463
7 Tranexamic acid Tablets 10x10 500 mg 1000
8 Tranexamic acid Injection 5ml Amp 100mg/ml-5ml amp 1000
Trifluoperazine 5mg+
Trifluoperazine+Trihexyphenidyl
9 Tablets 10x10 Trihexyphenidyl,
HCl
Benzhexol 2 mg 1000
V
8mg/ml- 1 ml
1 Valethamate Injection 1ml amp.
ampoules 179831
2 Vancomycin Injection vial Inj. 500mg vial 7475
3 Vassopressin Injection vial 20 I.U./ml 1000
4 Vecuronium Injection 2ml vial 4 mg/2ml- 2 ml vial 1000
5 Vincristine Injection 1ml amp. 1 mg/ml - 1 ml inj. 1000
Each ml contains-
Vitamin –‘A’ IP (As
palmitate)- 1,00,000
IU equivalent to about
100ml 109500 IU per gram.
amber Orange flavour 100ml
6 Vitamin A Syrup
coloured Amber coloured
bottle bottles with special
plastic white colour
spoon of 2ml size
with 1ml and 2ml
measure indication.
1000
As per Schedule-V of
Vitamin B Complex (For the Drugs and
7 Tablets
Prophylactic Use only) Cosmetics Rules,
1945 1000
8 Vitamin K/ Vitamin K3 Injection 100 mg/ml 8481
W
1 Water for Injection Injection amp. 2ml 1000
2 Water for Injection Injection amp. 5ml 1000
3 Water for Injection Injection vial 10ml 1000
X .
1 Xylometazoline Nasal Drop 10ml vial 0.1% - 10ml vial. 120110
2 Xylometazoline Nasal Drop 10ml vial 0.05% - 10ml vial 49163
Z
100ml 200mg/5ml - 100ml
1 Zinc sulphate Syrup
bottle bottle 1000
46
List of Surgical , Sutures and Consumables
Estimated
Consumption
Sl. Name of Items Dosage Form Unit Specification
Quantity (in
Nos.)
A
Surgical
1 Assorted sizes of 1000
Appliances
a. Kuntsher’s Nail 1000
b. DCP Plate 1000
c. Cancellous & Cortical
1000
Serum
d. Interlocking Nails 1000
e. Kirschenis Wire-1mm,
1000
1.5mm, 2.00mm
f. Stanhn steel wire no 22,24,
1000
20,18
g. Endor’s Nails of different
1000
sizes
h. Radial & Ulnar nails 1000
2 A.D. Syringe Surgical 2cc 1000
47
1 Roll of
8 Adhesive Tape Appliances 6.0" 1000
10cmx5m
9 ADK Drain 1000
1 B.P. Blade- Assorted Size No. 24 50816
2 B.P. Blade- Assorted Size No. 11/15 1941
As per the
specification
mentioned in
5 cm x 5
3 Bandage Surgical sch. F (II) of 37719
mt.
D &C rule
1945 : 5 cm x
5 mt.
As per the
specification
mentioned in
10 cm x 5
mt.
D &C rule
1945 : 10 cm
x 5 mt.
As per the
specification
mentioned in
15 cm x 5
mt.
D &C rule
1945 : 15 cm
x 5 mt.
6 Bandage Than Surgical Per Than 1000
Bipolar tip Prosthesis for urgical

7 1000
partial replacement Appliances
Plain No.-1
1 Catgut Suture 1 Pc (without 325
needle)
No.-1 (with
2 Catgut Chromic Suture 13229
needle)
48
No.-1
3 Catgut Chromic Suture (without 2801
needle)
No.-1 (with
4 Catgut Chromic Suture 3930
needle)
No.-2
5 Catgut Chromic Suture (without 7555
needle)
500gms roll,
6 Cotton (Absorbent) Cotton 400 gms roll 1000
net weight
7 Cottonthread No-10 Cotton No.-10 1000
8 Crape Bandage Dressings 1000
Surgical 3.2 mm, 2.5

1 Drill bits 3.2mm, 2.5mm 1000
Appliances mm
Surgical
1 Epidural Set 1000
Appliances
Epidural set with catheter & Surgical

2 1000
fitter Appliances
2000 ml., Top

Side non
return valve,
1 Urobag Appliances 1Pc. 4500
hanger
facility, 100
cm tubing
Folley's catheter Assorted No.- 18, 20, 1000 (each
2 Appliances 1Pc.
Sizes 22, 24 Product )
As per the
specification
mentioned in
1 Gauze than Dressings 18mtX90cm sch. F (II) of 156961
D &C rule
1945 :
18mtX90cm
49
As per the
specification
mentioned in
sch. F (II) of
2 Gauze than Dressings 9 mtX90 cm 1438
D &C rule
1945 : 9
mtX90
cm
3 Gloves Surgical 1Pc. No. 6 215489
4 Gloves Surgical 1Pc. No. 6.5 80500
5 Gloves Surgical 1Pc. No. 7 115719
6 Gloves Surgical 1Pc. No. 7.5 1000
Gypsona (Readymade
7 Dressings 1Pc. 15cm x 2.7 m 1000
Plaster Roll)
Gypsona (Readymade
8 Dressings 1Pc. 10cm x 2.7 m 1000
Plaster Roll)
Both for
1 I.V. Set Appliances 1Pc. Adult and 903541
Child
2 Scalpvain Set Surgical 1Pc. 1000
3 B.T. Set Appliances 1Pc. 863
4 Inracath/Safety Canula Surgical 1Pc. No.18 17969
9 IV Canula Appliances 50/500 No. 18 1000
50
1 Melecot Catheter Appliances 1Pc. 1000
2 Mersilk – 1/0, 1 Appliances 1Pc. 1/0, 1 1000
N
Nebuliser Solution
1 (Salbutamol, Ipratopium 1Pc. 1000
bromide)
Needle-Curve cutting &

2 1Pc. 1000
round body
3 Needle-Straight 1Pc. 1000
1 Paediatric Set/I.V. Set 1Pc. Adult/Child 1000
Containing
not less than
16%w/v of
sodium
phosphate
2 Proctoclyss Enema Solution 100 ml 1000
and 16%w/v
of
sodium acid
phosphate-
100ml
(15X15,
3 Prolin (15X15, 15X7) 1Pc. 1000
15X7)
4 Prolin 1/0, 2/0 1Pc. 1/0, 2/0 1000
5 Proline – 1/0, 2/0, 1 1Pc. 1/0, 2/0, 1 1000
1 Ready Made Adhesive 1Pc. 1000
Ready Made Adhesive

2 1Pc. Adult/Child 1000
traction kit - Adult/ Child
51
3 Roll Bandage- 4’’, 6’’ 1Pc. 4", 6" 1000
4 Ryles Tube- Assorted Size 1000
1 Safety Canula- Assorted Size Appliances 1000
2 Sanitary Towels 1000
3 Skeltal Traction kit 1000
Spinal Needle - Assorted No.- 22, 23, 1000 (Each

4 Surgical
Size 25, 26, 27 Product)
5 Spirit 1000
Syringe Disposable-2cc, 5 1000 (Each

6
cc, 10cc, Product)
1 Traction kit Adult/ Child Appliances Adult/Child 1000
2 Trochar & Canula 1000
3 Trypan Blue Opthalmic dilator 50 gm pkt. 1000
4 T-Tube - Assorted Size 1000
1 Urobag 4500
1 Vicoryl 1/0, 2/0 1/0, 2/0 1000
2 Vicryl – Assorted Numbers 1000
3 Viscomet Kit 1000
List of Surgical, Sutures as per Consumption Value (in Rs.)

Estimated
Sr.
Item Specification Consumtion Valu
No.
(in Rs.)
1 Adhesive Tape 4.0" 500000
52
2 Catgut Plain No.-2 (without
needle)
500000
3 Folley's catheter No.-8, 10, 12, 14,
Assorted Sizes 16, 500000
4 Foley's catheter No. 8 500000
5 Foley's catheter No. -10 500000
9 Surgical Paper Tape 9mX0.5" 500000
ANNEXURE-VII
Ref. Clause No.9.2 and 15.1
PACKING SPECIFICATIONS
I. SCHEDULE FOR PACKAGING OF LSCS KIT GENERAL SPECIFICATIONS
1. No corrugate package should weigh more than 15 kgs (ie. product + inner carton + corrugated box).
2. All items should be packed only in first hand boxes only.
3. All Corrugated boxes should be of `A' grade paper ie., Virgin.

FLUTE:
4. The corrugated boxes should be of narrow flute.
JOINT:
5. Every box should be preferably single joint and not more than two joints.
STITCHING:
6. Every box should be stitched using pairs of metal pins with an interval of two inches between each pair. The boxes should
be stitched and not joined using calico at the corners.
FLAP:
7. The flaps should uniformly meet but should not over lap each other. The flap when turned by 45 - 60 should not crack.
TAPE:
8. Every box should be sealed with gum tape/PVC tape running throughout the box along the top and bottom.
CARRY STRAP:
53
9. Every box should be strapped with two parallel nylon carry straps (they should intersect).
LABEL:
10. Every corrugated box should carry a large outer label in Green colour clearly indicating that the product is for "Bihar Govt.
Supply - Not For Sale". The lower one third of the large label should indicate in bold, as depicted in enclosure II of
Annexure II of this document.
11. The product label on the cartoon should be large at least 25cms x 15cms dimension. It should carry the correct technical name,
strength of the product, date of manufacturing, date of expiry, quantity packed and net weight of the box.
OTHERS:
12. No box should contain mixed products or mixed batches of the same product.
II. SPECIFICATION FOR CORRUGATED BOXES HOLDING TABLETS / CAPSULES / PESSARIES
(1) The box should not weigh more than 7-8 kgs. The grammage of outer box should be 150 gsm and inside partition / lining should
be 120 gsm.
(2) The box should be of 5 ply with Bursting strength of 9 Kg/ Cm2
III. SPECIFICATION FOR LARGE VOLUME BOTTLE i.e., ABOVE 120 AND BELOW 1 LIT.
(1) All these bottles should be packed only in single row with partition between each and also with top and bottom pad of 3 ply.
(2) Grammage : Outer box should be 150 gsm inside partition / lining should be 120 gsm.
(3) Ply : 7 Ply.
(4) Bursting Strength : Not less than 12 Kg/Cm2
IV. SPECIFICATION FOR IV FLUIDS
(1) Each corrugated box may carry a maximum of only 24 bottles of 500 ml in a single row or 50 bottles of 100 ml in 2 rows with
individual sealed polythene cover and centre partition pad, top and bottom pads of 3 ply.
(2) Grammage : Outer box should be 150 gsm inside partition / lining should be 120 gsm
(3) Ply : 5 or 7
V. SPECIFICATIONS FOR LIQUID ORALS 50ml to 120 ml bottles.
(1) 100 bottles of 50ml or 60ml may be packed in a single corrugated in 2 rows with top, bottom and centre pad of 3 ply. 50 bottles
of 100 ml - 120 ml may be packed in a similar manner in a single corrugated box.
54
(2) If the bottles are not packed in individual carton, 3 ply partition should be provided between each bottle. The measuring device
should be packed individually.
(4) Ply : 7 ply
(6) In case the box is heavier than 7 Kg but less than 10 kg, the grammage may be 150 gsm (outer 150 gsm and others 120 gsm) 5 ply
and bursting strength should not be less than 9 Kg/Cm2.
VI. SPECIFICATIONS FOR OINTMENT / CREAM / GELS PACKED IN TUBES:
(1) No corrugate box should weigh more than 7-8 Kgs.
(2) Every Ointment tube should be individually packed in cartoon and then packed in 20's in a grey board box, which may be packed
in a corrugated box.
VII. SPECIFICATIONS FOR INJECTABLE (IN VIALS AND AMPOULES)
(1) Vials may be packed in corrugated boxes weighing upto 15 Kgs. Ampoules should be packed in C.B weighing not more than 8 kgs.
(2) C.B. for vials should be of 150 Gsm (outer box should be 150 gsm and inside partition / lining should be 120 gsm) and 7 ply, while
C.B. for ampoules should be of 150 Gsm (outer box should be 150 gsm and inside partition / lining should be 120 gsm) and 5 ply.
(3) Bursting strength for CB boxes for
a. Vials : Note less than 13 Kg/Cm2
b. Amp : Note less than 9 Kg/Cm2
(4) In the case of 10 ml Ampoules 100 or 50 ampoules may be packed in a grey board box. Multiples of grey board boxes packed in
CB. In case of ampoules larger than 10 ml only 25 ampoules may be packed in a grey board box with partition.
(5) If the vial is packed in individual cartoon, there is no necessity for grey board box packing. The individual cartoon may be packed
as such in the CB with centre pad.
(6) In case of ampoules every grey board box should carry 5 amps. Cutters placed in a polythene bag.
(7) Vials of eye and ear drops should be packed in an individual cartoon with a dispensing device. If the vial is of FFS/BFS technology,
they should be packed in 50's in a grey board box.
VIII. SPECIFICATIONS FOR “ORS”
(1) The sachets should be of Aluminium Foil laminated with glassing or heat sealable plastic film, Outer paper may contain label
information.
(2) 50 sachets may be packed in grey board boxes and 10 grey board boxes in a C.B.
(4) Ply : 5
55
(5) Bursting Strength : Not less than 9 Kg/Cm2.
IX. LYSOL
(1) Not more than 5 litres cans may be packed in a single CB.
(3) Ply : 7 Ply
(4) Bursting Strength : Not less than 12 Kg/ Cm2
56
ANNEXURE-VIII
Ref. Clause No. 12(a)
AGREEMENT
This Deed of Agreement is made on this ___________ day of____________________2013 by M/s._____________________ represented by its
Proprietor/Managing partner/ Managing Director having its Registered Office at ________________________________________________
and its Factory Premises at ___________________________________________________________ (hereinafter referred to as “Supplier”
which term shall include its successors, representatives, heirs, executors and administrators unless excluded by the Contract) on one part and
Govt. of Bihar., represented by its Managing Director of Bihar Medical Services and Infrastructure Corporation Ltd.(BMSICL)having his Office at
Patna (hereinafter referred to as “The Purchaser” which term shall include its successors, representatives, executors assigns and
administrators unless excluded by the Contract) on the other part. Where as the Supplier has agreed to supply to the Purchaser, the Drugs and
Medicines with specifications mentioned in the Schedule attached here to at the prices noted there in and in the manner and under the terms
and conditions here in after mentioned and where as the Supplier has deposited with the Purchaser a sum of
Rs_____________________________(Rupees_____________________________________________________________________
only) as Security Deposit for the due and faithful performance of this Agreement, to be forfeited in the event of the Supplier failing duly and
faithfully to perform it. Now these presents witness that for carrying out the said Agreement in this behalf into execution the Supplier and the
Purchaser do hereby mutually covenant, declare, contract and agree each of them with the other of them in the manner following, that is to
say,
01. The term “Agreement”, wherever used in this connection, shall mean and include the terms and conditions contained in the invitation to
tender floated for the supply of Drugs and Medicines to various medical institutions of GOB for the year 2011-2012, the instructions to
tenderers, the conditions of tender, acceptance of tender, particulars hereinafter defined and those general and special conditions that may
be added from time to time.
02. (a) The Agreement is for the supply by the Supplier to the Purchaser of the Drugs and Medicines specified in the Schedule attached hereto
at the prices noted against each therein on the terms and conditions set forth in the Agreement.
(b) This Agreement shall be deemed to have come into force with effect from the _______ and it shall remain in force for a period of up to
…………………….. that date with effect from………………….
© The Tender quantity noted against each item in the Schedule attached hereto indicates only the probable total requirements of the
Purchaser in respect of each item for the Agreement Period of 12 months indicated in Clause (b) above. This quantity may increase or decrease
at the discretion of the Purchaser. The Supplier shall make supplies of the Drugs and Medicines on the basis of the Purchase Orders placed on
him from time to time by the Ordering Authorities of the purchaser specifying the quantities required to be supplied at the specific location in
the state of Bihar.
QUALITY OF THE DRUGS AND MEDICINES TO BE SUPPLIED: SHELF LIFE OF DRUGS AND MEDICINES TO BE SUPPLIED:
03. (a) The Drugs and Medicines supplied by the supplier at district store shall have shelf life as given below:
(i) In respect of each of the items covered in Schedule ‘P’ of the Drugs and Cosmetics Act 1940, not less than 75% of the maximum permissible
life period specified in the said Schedule of the said Act.
(ii) In respect of all other items, a period of minimum 2 years or not less than 75% of the shelf from the date of manufacture
.04. (a) The Drugs and Medicines supplied by the Supplier shall be of the best quality and shall comply with the specifications, stipulations
specified in the Schedule attached hereto and read with the Conditions of Tender.
(b) In respect of any case, where a sample of the product to be supplied by the Supplier has been examined and approved by the Purchaser,
the supplies must be equal in all respects to the sample approved by the Purchaser.
© If the shelf life of the drug supplied is less than the period that prescribed in the tender condition, then the supplier shall take back the stock
so supplied at his cost.
57
PACKAGING SPECIFICATIONS:
05. (a) The stipulations pertaining to Packaging as detailed for each item in Annexure read with Clause 15 of the “Conditions of Tender” shall
be strictly adhered to by the Supplier.
(b) Final packing shall be done in corrugated Fibre Board Boxes conforming to the specifications laid down in Annexure of the “Conditions of
Tender” with suitable cushioning and lining, strong enough to bear the rail, road and air transit hazards.
© Case wood packing, if used for final packing, shall be of ISI Standard with suitable preservatives, if these are made of nonconiferous timber.
(d) The packing shall be subject to the approval of the Purchaser.
(e) Goods supplied without conforming to the packaging specifications noted herein and in the Conditions of Tender, shall be liable to be
rejected by the Purchaser. The Purchaser shall also have the right to reject any goods whose packaging is in a damaged condition at the time of
delivery.
PLACE AND TIME OF SUPPLY:
06. (a) The supplier should supply at least 20% of the ordered quantity at the specified locations as per the schedule within 30 days from the
th
date of purchase order and at least 70% of the ordered quantity at specified locations within 45 day from the date of purchase order,
st th
otherwise ordering authority will have the right to place orders not exceeding 30% of the ordered quantity from 31 day up to 45 day from
th
the date of purchase order and up to 50% of the order quantity after 45 day from the of purchase order respectively, on any other matched /
unmatched supplier at the discretion of ordering authority. The risk and differential cost will be passed on to the original supplier.
(b) If supplies are not fully completed in 45 days from the date of the Purchase Order, the provision of clause 18.2 and 18.3 of Tender
conditions will come into force. The Supplier shall suffer forfeiture of the Earnest Money Deposit / Security Deposit too. The Supplier should
supply the drugs at the Warehouse specified in the Purchase Order and if the drugs supplied at a designated places other than those specified
in the Purchase Order, transport charges will be recovered form the supplier.
© If the supplier fails to execute at least 50% of the quantity mentioned in single Purchase order and such part supply continues for three
consecutive Purchase orders, then the supplier will be ineligible to participate in any of the tenders for particular items of drugs / medicines for
a period of one year immediately succeeding year in which supplier has placed Purchase order.
QUALITY TESTING:
07. (a) All the Drugs and Medicines supplied by the Supplier shall be subjected to rigorous Analytical Testing for their quality. Samples of each
batch of each product supplied will be drawn at the points of supply or distribution / storage and send by the Purchaser to different Analytical
Laboratories selected by him at his discretion for testing. The samples will be drawn periodically through out the shelf life period. The
expenditure towards the Handling and Testing of such samples will be borne by the Supplier at the rates fixed by the Purchaser.
(b) If any articles or things supplied by the Supplier have been partially or wholly used or consumed after supply and are subsequently found to
be in bad odour, unsound, inferior in quality or description or are otherwise faulty or unfit for consumption, then the contract price or prices of
such articles or things will be recovered from the Supplier, if payment had already been made to him. Otherwise the Supplier will not be
entitled to any payment whatsoever for such article. For infringement of the stipulations of the contract or for other justifiable reasons, the
contract may be terminated by the ordering authority and the Supplier shall be liable for all losses sustained by the Purchaser in consequence
of the termination which may be recovered personally from the tender or from his properties, as per rules.
© The Supplier shall furnish the source of procurement of raw materials utilized in the formulations as required by Purchaser. Purchaser
reserves the right to cancel the Purchase Orders, if the source of supply is not furnished.
(d) (i) During the contract period if two batches of the particular item supplied by the firm fails in ASSAY content then the
58
product of that particular firm will be blacklisted.
(ii) During the contract period if three batches of the particular item supplied by the firm fails in quality test (ASSAY content, description test
and other parameters mentioned in pharmacopoeia.) then that particular item will be blacklisted for the firm.
(iii) In respect of the firm supplying more than one item during the contract period if more that 50% of the items are blacklisted based on the
above process, then the Firm will be blacklisted.
(iv) In case of any sample in even one batch declared as spurious or adulterated or misbranded by the Government Analyst, the company will
be blacklisted.
REJECTION OF STOCK WHICH FAILS IN QUALITY TESTING:
08. The supplies will be deemed to be completed only upon receipt of reports of quality testing of the samples from the testing laboratories If
supplied drug fail in quality then supplier will either have to lift the whole lot/batch at their own cost within 30 days and pay the equivalent
amount by draft to procure apart from other penalty as per contract. If the lot is not lifted within 30 days it will be destroyed and all cost,
including the cost of destruction will be recovered from supplier. No payment will be made for the entire rejected/substandard batch of that
particular item, even if the supplies have been consumed in good faith. If the payment has already been made and they fail to pay the amount
then amount will be adjusted from the pending bills for the supplier firm or security deposit. An additional 10% of the cost of Not of Standard
Quality Drugs shall be deducted to meet the cost of handling sub standard drugs. In no circumstances, request for replacement of sub standard
drugs by the supplier shall be entertained. Further, action will be initiated for blacklisting of the product/firm and legal action as per the rule
and prevailing issued by Drug Controller General (India). The Supplier shall also be liable for action under Criminal Law and the appropriate
authorities will be informed for initiating necessary action. The Supplier shall be blacklisted for the product and no further supplies accepted
from him. The Supplier shall also be declared to be ineligible to participate in any Tender floated by the Purchaser for a period of next 5 years
for the product in question. The Purchaser at his discretion may also terminate the Contract and in case of such termination, the Supplier shall
be liable for all losses sustained by the Purchaser in consequence of such termination, which may be recovered from the Security Deposit
made by the Supplier and / or any other money due or becoming due to him. In the event of such amounts being insufficient, the balance may
be recovered personally from the Supplier or from his properties as per the provisions of Law. In case of such termination of Contract, the
Supplier shall be blacklisted for all supplies to the Purchaser for a period of 5 years.
INSPECTION OF THE SUPPLIER’S FACTORY:
09. In respect of the items mentioned in the Schedule, the Supplier shall allow inspection of his factory at any time during the continuance of
the Tender period by a team of Experts / Officials whom the Purchaser may depute for the purpose. The Supplier shall extend all facilities to
the team to enable them to inspect the manufacturing processes, quality control measures adopted, etc., in the manufacture of the
Contracted items. The Purchaser is free to terminate the Contract and / or take penal action against the Supplier as per the provisions of the
“Conditions of Tender” on the basis of the results of such inspections.
DIFFERENCES IN COST TO BE RECOVERED FROM SECURITY DEPOSIT OR AMOUNTS DUE
10. In the event of
(i) The samples of Drugs and Medicines supplied, failing quality tests, or
(ii) The Supplier failing to effect supplies within the time period stipulated in Paragraph 6 of this Agreement, or
(iii) The stocks supplied being found to be not as per specifications stipulated in the Schedule attached hereto or in the Tender, in respect of
either the products themselves or their packaging. The purchaser will be free to make alternative purchases of the Drugs and Medicines in
question from any other source or in the open market or from any other Tenderer who might have quoted higher rates at the risk and cost of
the Supplier, in addition to levying other penalties specified in “Conditions of Tender” and forfeiting the Security Deposit made by the Supplier.
The excess expenditure over and above the contracted prices incurred by the Purchaser in making such purchases from any other source or in
the open market or from any other Tenderer who has quoted higher rates, and other losses, if any, sustained in the process by the Purchaser
shall be recovered from the Security Deposit of the Supplier or from any money due or becoming due to him and in the event of such amounts
being insufficient, the balance will be recovered personally from the Supplier as per law.
ACCEPTANCE OF DELAYED SUPPLIES AND LEVY OF LIQUIDATED DAMAGES THEREFOR
59
11. In all cases where the Supplier fails to complete the supplies of any of the Drugs and Medicines ordered by the Purchaser within the time
specified in Paragraph 6 herein, the Supplier shall be liable to pay to the Purchaser, as and by way of Liquidated Damages, 0.5% (half percent)
of the value of the delayed supplies for each day of delay in effecting the supply as per condition of Tender. The levy of such liquidated
damages by the Purchaser shall be made irrespective of the Purchaser having actually suffered any damages / losses or not, on account of the
delay in effecting supplies by the Supplier.
DELAYS IN EFFECTING SUPPLIES DUE TO CIRCUMSTANCES BEYOND CONTROL OF THE SUPPLIER
12.If, at any time during the continuance of this Agreement, the Supplier has, in the opinion of the Purchaser, delayed in making any supply
ordered, by the reasons of any riots, mutinies, wars, fire, storm, tempest or other exceptional cause, on a specific request made by the
Supplier, the time for effecting delivery may be extended by the Purchaser surely at his discretion for such period as may be considered
reasonable by the Purchaser. No further representation from the Supplier will be entertained on this account.
RECOVERY OF MONEY DUE TO THE PURCHASER FROM THE SUPPLIER
13.All expenses, damages and other moneys payable to the Purchaser by the Supplier under any provisions of this Agreement may be
recovered from the amounts due or subsequently becoming due from the Purchaser to the Supplier under this or any other Agreement. In
case such amounts are insufficient to fully cover such expenses, damages or other moneys payable, it shall be lawful for the Purchaser to
recover the balance amount from the Security Deposit of the Supplier and in case such Security Deposit is insufficient, then it shall also be
lawful for the Purchaser to recover the residue of the said expenses, damages and moneys, if necessary, by resorting to legal proceedings
against the Supplier.
AMOUNT OF SECURITY DEPOSIT TO BE MADE BY THE SUPPLIER
14.The Supplier shall deposit with the Purchaser an amount of Rs______________ (as in Tender condition) as Security Deposit as specified in
Clause 11 of the Conditions of Tender for due and faithful performance of the provisions of this Agreement. Such Security Deposit made by the
Supplier is liable to be forfeited by the Purchaser in the event of the Supplier failing duly and faithfully to perform any one or more or any part
of any one of the said provisions. The amount of
Security Deposit shall be remitted by the Supplier to the Purchaser by way of a Demand Draft favouring the Director, Medical Services, Govt. of
Madhya Pradesh. The payment for the supplies made by the Supplier will be paid to him only after he has remitted the required amount of
Security Deposit.
SUBMISSION OF BILLS FOR SUPPLIES MADE
15. All bills / invoices should be raised in triplicate in the name of the ordering authority.
PROCEDURE FOR PAYMENT
16. (a) No advance payment towards the cost of Drugs and Medicines will be made to the Supplier. Payment of cost of the supplies will be
made by the Purchaser based on the reports of Quality Testing and “Materials Received Certificates” from the designated authorities at the
points of supply as mentioned in the Purchase Order.
(b) All payments shall be made by way of cheques drawn in favour of the Supplier and Crossed Account Payee only.
ASSIGNMENT OF CONTRACT PROHIBITED
17. The Supplier shall not, at any time, assign, sub-let or make over the present Contract or the benefits thereof or any part thereof, to any
person or persons whomsoever.
TERMINATION OF CONTRACT ON BREACH OF CONDITION
60
18. (a) In case the Supplier fails or neglects or refuses to faithfully perform any of the Covenants on his part herein contained, it shall be lawful
for the Purchaser to forfeit the amount deposited by the Supplier as Security Deposit and cancel the Contract.
(b) In case the Supplier fails, neglects, or refuses to observe, perform, fulfill and keep, all or any one or more or any part of any one of the
Covenants, stipulations and provisions herein contained, it shall be lawful for the Purchaser on any such failure, neglect or refusal, to put an
end to this Agreement and thereupon every article, cause and thing herein contained on the part of the Purchaser shall cease and be void, and
in case of any damage, loss, expense, differences in cost or other moneys than or at any time during the continuance of this Agreement
becoming due or owing by the Supplier to the Purchaser, it will be opened for the Purchaser to recover from the Supplier, all such damages,
losses, expenses, differences in cost or other moneys from out of any moneys for the time being payable to the Supplier under this and / or
any other Contract and in case such last mentioned moneys are insufficient to cover all such damages, losses, expenses, differences in cost and
other moneys as aforesaid, it shall be lawful for the Purchaser to appropriate the Security Deposit made by the Supplier as herein before
mentioned to reimburse all such damages, losses, expenses, differences in cost and other moneys as the Purchaser shall have sustained,
incurred or been put to by reason of the Supplier having been guilty of any such failure, negligence or refusal as aforesaid or other breach in
the performance of this Contract.
© If at any time during the course of the Contract, it is found that any information furnished by the Supplier to the Purchaser, either in his
Tender or otherwise, is false, the Purchaser may put an end to the Contract / Agreement wholly or in part and thereupon the provisions of
Clause (a) above shall apply.
19. The Purchaser reserves the right to terminate without assigning any reasons therefore the Contract / Agreement either wholly or in part
without any notice to the Supplier. The Supplier will not be entitled for any compensation whatsoever in respect of such termination of the
Contract / Agreement by the Purchaser.
NOTICES ETC. IN WRITING
20. All Certificates or Notices or orders for time or for extra, varied or altered supplies which are to be the subject of extra or varied charges
whether so described in the Agreement or not, shall be in writing, and unless in writing, shall not be valid, binding or be of any effect
whatsoever.
SUPPLIERS NOT TO HAVE ANY INTEREST IN THE OFFICERS CONCERNED AND SUBORDINATES
21. The Supplier shall not be in any way interested in or concerned directly or indirectly with, any of the Officers, Subordinates or Servants of
the Purchaser. In any trade, business or transactions nor shall the Supplier give or pay or promise to give or pay any such Officer, Subordinate
or Servant directly or indirectly any money or fee or other consideration under designation of “Custom” or otherwise; nor shall the Supplier
permit any person or persons whomsoever to interfere in the management or performance hereof under power of attorney or otherwise
without the consent in writing of the Purchaser obtained in first hand.
BANKRUPTCY OF THE SUPPLIER
22. In case the Supplier at any time during the continuance of the Contract becomes bankrupt or insolvent or commits any act of bankruptcy or
insolvency under the provisions of any law in that behalf for the time being in force, or should compound with his creditors, it shall be lawful
for the Purchaser to put an end to the Agreement, and thereupon every article, clause and thing herein contained to be operative on the part
of the Purchaser, shall cease and be void and the Purchaser shall have all the rights and remedies given to him under the preceding clauses.
SERVING OF NOTICES ON SUPPLIER
23. All notices or communications relating to or arising out of this Agreement or any of the terms thereof shall be considered duly served on or
given to the Supplier if delivered to him or left at his premises, place of business or abode.
24. And it is hereby agreed and declared between the parties hereto that in case any question of dispute arises touching the construction or
wording of any clause herein contained on the rights, duties, liabilities of the parties hereto or any other way, touching or arising out of the
presents, the decision of the Director of Medical Services in the matter shall be final and binding.
25. In the event of any disputes between the parties, the disputes would be subject to the jurisdiction of the Court of Bihar or Honorable High
Court of Bihar. In witness whereof the Supplier and the Director, Medical Services acting for and on behalf of the ordering authority and Govt.
of Madhya Pradesh, the Purchaser, have set their hands the day, month and year first above written.
61
SCHEDULE OF AGREEMENT
(Selected L1 items)
S.N Drug Code Name of drug Unit L1 Rate (Rs./P) Tender Value
Quantity
Matched L1 Item
S.N Drug Code Name of drug Unit L1 Rate Quoted rate Matched Quantity Value
(Rs./P) rate
IN WITNESS whereof the parties hereto have caused this Agreement to be executed in accordance with their respective laws the day and
year first above written.
That, in token of this agreement, both parties have today affixed their signatures at …………….
Signed, Sealed and delivered by the
said ....................................(For the Purchaser)
in the presence of :......................................
Signed, Sealed and Delivered by the
said ...........................................(For the Supplier)
in the presence of: ..........................................
62
ANNEXURE - IX
Ref. Clause No. 4.1(n)
DETAILS OF MANUFACTURING /IMPORTING UNIT
Name of the Tenderer & Full Address :
PAN Number :
Phone Nos. :
Fax No. :
E-Mail address :
Date of Inception :
Drug Manufacturing Licence No. & Date :
Issued by :
Valid up to :
CST/VAT Registration No. :
Details of Installed Production Capacity for 60 days / 1 year (In Terms of Unit Packs)
Tablets :
Capsules
General :
Beta-Lactum :
Injections
Ampoules :
Vials :
I.V.Fluids :
Sterile Powder :
Liquids
Suspension :
Syrups :
Drops :
63
Ointment :
Powders :
Antiseptics /
Disinfectants :
Name & designation of the authorised signatory :
Specimen signature of the authorized Signatory :
* The details of manufacturing unit shall be for the premises where items quoted are actually manufactured
64
ANNEXURE - X
Ref. Clause No. 21
PROCEDURE FOR BLACKLISTING OF PRODUCT / TENDER IF ANY WITHDRAWAL OF TENDERER
1. BLACKLISTING FOR QUALITY FAILURE.
A. Problem of Potency
If one batch of particular items supplied by the supplier fail in test for ASSAY content , the particular item of the drug supplied
by the manufacturer shall be blacklisted as per details given below:
a. If variation in ASSAY content is up to 5% in one batch of drug/product supplied, blacklisting for that particular
drug/product shall be for two year;
b. If variation in ASSAY content is up to 10% in maximum two batches of drug/product supplied , the blacklisting for that
particular drug /product shall be for three year;
c. If variation in ASSAY content is more than 10% in any of the batch the drug/ product , the firm shall be blacklisted for
five year;
d. If variation in ASSAY content is more than 5% in 2 or more products supplied by the same supplier , the firm shall be
blacklisted for 5 years;
B. Spurious / Adulterated /Misbranded Drugs
If any sample of any batch is found to be spurious or adulterated the manufacturer will be blacklisted for five years and
legal action will be initiated against the firm. If it is misbranded the firm shall be blacklisted for minimum period of 1 year.
2. Blacklisting For Other Reasons

a. The Successful tenderers fail to execute the agreement, to perform the obligations under the tender conditions and commits
default in the performance of the contract, such tenderers will be blacklisted for a minimum period of 1 years.
b. The tenderers who have withdrawn after participating in the tender will be ineligible to participate for a period of 2 years.
65
ANNEXURE – XI
Ref. clause 4.1
List of Items quoted
1. Name of the firm and address as given in Drug licence :

2. Drug Licence No. in form 25 & 28 or import Licence No. :
3. Date of issue & validity :
4. Revised schedule M compliance Certificate obtained on :
5. Non-conviction Certificate Obtained on :
6. Market standing Certificate obtained on :
7. Details of Endorsement for all products quoted :
S.N Drug Code Drug name Specifications Date of Whether

Endoresement Endorsement is
IP/BP/USP obtained from in generic or
the State drug trading name
Controller
Authorised signatory :
Seal
Date :
66
CHECK LIST ANNEXURE - XII
Ref. Clause. 4.1
COVER - A.
Checklist – The tenderer should furnish the following in a separate cover hereafter called "Cover A". Yes No
1. EMD in the from of DD shall be kept in an envelope Yes No

2. Documentary evidence for the constitutions of the company / concern Yes No
3. Duly attested photocopy of Licence for the product duly approved by the Licencing authority for each
and every product quoted. Yes No
4. Duly attested photocopy of Import Licence, if imported. Yes/No
5. Income Tax return for last 3 years Yes No
6. The instruments such as power of attorney, resolution of board etc., Yes No
7. Authorization letter nominating a responsible person of the tenderer to transact the business
with the Tender inviting Authority. Yes No
8. Market Standing Certificate issued by the Licensing Authority as per annexure IV Yes No
9. Non Conviction Certificate issued by the Drugs Controller Yes No
10. Good Manufacturing Practices Certificate (WHO GMP/cGMP) Yes No
11. Annual Turnover Statement for 3 Years (Annexure-V) Yes No
12. Copies of audited balance sheet & profit loss account for three years Yes No
13. Annexure-I (Sales Tax clearance certificate) Yes No
14. Annexure-II (Undertaking for embossment of logo) Yes No
15. Declaration Form in Annexure-III Yes No
16. Details of Manufacturing/Importing Unit in Annexure-IX Yes No
17. The Tender document signed by the tenderer in all pages with office seal. Yes No
67
ANNEXURE – XIII
Ref-clause. 5
SUGGESTED SAMPLE PROFORMA OF PRICE SCHEDULE FOR THE
SUPPLY OF DRUGS & MEDICINES
S. DRUG CODE Name of Unit Manufact Quantity Rate per Unit * † Rate of
No.
the item uring offered by (Landed Price) Excise/Custom
(2)
as per Capacity bidder Duty included in
(1) (Inclusive of Excise/Custom Duty,
Specificati (5) (6) quoted Rate per
ons & transportation, packing, insurance, unit
dosage (4) DIRECTOR, DRUGS PROCUREMENT
form CELL, DOPH&FW service charge,
inspection charges and any incidental
(3)
charges etc, if any
(7)
(8)
In figure In Words
Rs. P.
(1) * † The rate quoted at column 7 should be in accordance to unit mentioned at coloum 4.
Note: This format of price schedule is a sample for the Bidder's. The bidder's are instructed to fill the rates in prescribed price
schedule available on Portal.
Price schedule should not be submitted in Technical Bid, other wise tender shall be rejected.
68
Annexure-XIV
Ref. Clause No. 5
Break up of Landed price per unit
No. Drug Name of Basic Price Packing & Excise / Freight Total Sales
the Drug landed
Code Inclusive of Forwarding Customs Insurance Tax
Price
Incidental Charges Duty Charges
(4+5+6+7)
Services
1 2 3 4 5 6 7 8 9
Note: The firms shall indicate the break up prices at Column 4 to 7 and 8 separately and wording like
“Included” shall not be substituted for the same.
Place : Signature :
Name in Capital Letters :
Designation :
Seal:
Date:
69
ANNEXURE -XV
Ref. Clause No. 11
PERFORMANCE SECURITY FORM
[The bank, as requested by the successful Bidder, shall fill in this form in accordance with the instructions indicated]
________________________________
[Bank’s Name, and Address of Issuing Branch or Office]
PERFORMANCE GUARANTEE No.:______________ Date: ________________
To: ……………………………………………………………… (Name of Purchaser/ Beneficiary)
We have been informed that ………………………………….[insert complete name of Supplier] (hereinafter called "the Supplier") has
entered into Contract with you, for the supply of …………………………….[Brief description of Goods and related Services] (hereinafter called "the
Contract").
Furthermore, we understand that, according to the conditions of the Contract, a Performance Guarantee is required.
At the request of the Supplier, we hereby irrevocably undertake to pay you any sum(s) not exceeding ………………………[insert amount(s) in
figures and words] upon receipt by us of your first demand in writing declaring the Supplier to be in default under the Contract, without cavil
or argument, or your needing to prove or to show grounds or reasons for your demand or the sum specified therein.
This guarantee is valid until the ............ day of .................2013.
Signature and Seal of Guarantors
......................................................
......................................................
......................................................
Date ......................... 2013
Full Address of the Bank: ...........
.....................................................
.....................................................
70
ANNEXURE-XVI
(Refer 4.1(d)
MANUFACTURER'S AUTHORISATION LETTER
No................................................ Dated.....................................
To,
................................................................
................................................................
................................................................
Dear Sir,
Tender No. ...................................................................................
We ................................................. an established and reputable Manufacturers of ................................................... having factories at

.................. and ..................... do here by agree to supply ............................................. confirming to the required specification and required
quantity to M/s. ............................................................................... (Bidder) as offered by them to supply against the above stated Tender. This
is also certified that M/s ................................................................................. is our authorised distributor / Importer since
..................................... ( month & year should filled), and his performance is satisfactory.
We hereby extend our full guarantee and warranty as per the General Conditions of Contract for the supply against this invitation
for Bid by the above firm.
Yours faithfully,
(name)
for and on behalf of M/s ........................................................................(Name of manufacturers)
Note: This letter should be signed by a person competent and having authority to sign on behalf of manufacturer, and should be duly
Notarized.
71
Annexure-XVII (Refer Clause-4.1(o)
Technical Evaluation Chart - Part A

Basic Information of Bidders
EMD
Amoun Audited Balancesheet
Sale & Profit & Loss A/c - Avg. Turnover for F.Y 2009-
Legal Staus Bid for t ,DD Income Tax Return for
Tax/VA
Nam Manuf with date Drug No.,,D clause 4.1(k) 10,10-11 and 11-12 - clause Remarks
Bid T A.Y - clause 4.1(i)
e & acturer of or ate & [Submitted/Not 2(b) [Rs. In Lakhs]
No Registr
Addr /impor constitutio Surgica Bank Submitted]
. ation-
ess ter n- clause l or Name -
clause
4.1(b) both Clause
4.1(l)
4.1(a)
&7
Avg.
2010- 2011 2012 2009 2010 2011 2009 2010 2011 Turn
11 -12 -13 -10 -11 -12 -10 -11 -12 over
72
Annexure-XVII( Refer Clause-4.1(o)
Technical Evaluation Chart Part- B

Technical Information of Bidders
Submissi
Manufacturing on of
License with Market duly filled
Power of upto date Standing cGMP/ and
Non Affadavit
Attorney License Certificate WHO Signed
Name Conviction for non Paper
Bid or Renewal for each GMP/c Annexure
& Certificate- blacklisti Attested
No. Resolution certificate and product OPP- s- Clause-
Address clause ng- clause By
- clause- their renewed quoted- clause 4.1(n)[su
4.1(g) 4.1(j)
4.1(e) product list- clause 4.1(h) bmitted
clause 4.1 © & 4.1(f) /not
(d) submitte
d]
Note: Name of quoted Products, their renewed approval with relevant page no, their market standing with
relevant page no. shall be mentioned row-wise separately on the Technical evaluation chart.
73

Tender Ref. No BMSICL/DRUGS/01/2013)

Uploaded by

Copyright:

Available Formats

Tender Ref. No BMSICL/DRUGS/01/2013)

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Tender Ref. No BMSICL/DRUGS/01/2013)

Uploaded by

Copyright:

Available Formats

BID DOCUMENT FOR SUPPLY OF DRUGS & MEDICINES FOR VARIOUS

MEDICAL INSTITUTIONS OF GOVT. OF BIHAR FOR THE YEAR 2013-14

(Tender Ref. No BMSICL/DRUGS/01/2013)

BIHAR MEDICAL SERVICES AND INFRASTRUCTURE CORPORATION LTD. (BMSICL)

DEPARTMENT OF HEALTH, GOVT. OF BIHAR

5th FLOOR, BISCOMAUN BHAWAN,GANDHI MAIDAN,PATNA-800001

CONTACT NO.0612-2219634, 2219635

TENDER REFERENCE : BMSICL/DRUG/01/2013, dt…………

DATE OF COMMENCEMENT OF SALE OF TENDER: 18.02.2013

TIME AND DATE OF OPENING OF TENDER : 15.03.2013 at 12.30 P.M.

PLACE OF SUBMISSION AND OPENING OF TENDER : 5TH FLOOR,BISCOMAUN BHAWAN, PATNA-1

Sr. No. Particulars Clause No.

MEDICAL INSTITUTIONS OF GOVT. OF BIHAR FOR THE YEAR 2013-14

GENERAL INSTRUCTIONS TO BIDDERS;

4. TECHNICAL BID -COVER “A”

5. PRICE BID - COVER ”B”

1. Cover “B” will contain Price Bid of the Tenderer.

6. OPENING OF COVER “A” AND COVER “B” OF TENDER

8. EARNEST MONEY DEPOSIT EXEMPTION

10. ACCEPTANCE OF TENDER

b) Balance 5% will be deducted from the running bill of the Tenderer.

Vii) Packing should be able to prevent damage or deterioration during transit.

16. QUALITY TESTING

18. DEDUCTION IN PAYMENTS:

19. QUALITY CONTROL DEDUCTION & OTHER PENALTIES:

20. BLACKLISTING PROCEDURE

Item No. Topic Page No.

1. Annexure-I (Sales Tax Clearance Certificate)

2. Annexure-II (Undertaking Form)

3. Annexure-III (Declaration Form)

4. Annexure-IV (Proforma for Performance statement)

5. Annexure-V (Annual Turnover Statement)

6. Annexure-VI (Specification of required drugs and medicines )

7. Annexure-VII (Packing Specification)

8. Annexure-VIII (Contract Agreement form)

9. Annexure-IX (Details of Manufacturing Unit)

10. Annexure-X (Procedure for Blacklisting)

11. Annexure-XI (List of Items Quoted)

12. Annexure-XII (Check List)

13. Annexure XIII (The Landed price)

14. Annexure XIV (Break up Details of landed price)

15. Annexure XV (Performance Security Form)

16. Annexure XVI (Manufacturer Authorization Letter)

PATRONAGE AT THE DISPOSAL OF THE GOVERNMENT OF BIHAR.

(To be filled up by the applicant)

b. Places of business of the applicant (All places of business should be mentioned).

b. Particulars of Sales - Tax/VAT for the preceding three years.

e. The name and address of Branches if any:

(To be filled up by the Assessing authority) : OPTIONAL

Date Seal : Deputy / Asst. Commercial Tax – Officer

Signature of the bidder

Name in capital letters with Designation & official seal

Attested by Notary Public.

DESIGN FOR LOGOGRAM

" For Bihar Govt. Not for sale "

The vials should be supplied with aluminum seals containing

Refer Clause no. 14

SPECIMEN LABEL FOR OUTER CARTON

NOT FOR SALE